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Psychological aspects and stress-related hormones in M enière’s disease
1. De ziekte van Menière heeft een grote impact op de kwaliteit van 
leven (dit proefschrift).
2. Menière-patiënten hebben geen afwijkend persoonlijkheidsprofiel 
(dit proefschrift).
3. Verhoogde stresshormoonspiegels zijn eerder een gevolg dan een 
oorzaak van de ziekte van Menière (dit proefschrift).
4. Sommige Menière-patiënten belanden in een vicieuze cirkel van 
klachten en psychologische problemen (dit proefschrift).
5. De diagnose ziekte van Menière wordt regelmatig onterecht gesteld.
6. Het is soms belangrijker te weten wat voor persoon een ziekte heeft, 
dan wat voor ziekte een persoon heeft.
7. Rokers dienen een hogere ziektekostenpremie te betalen.
8. Door je van alles wijs te laten maken, is nog nooit iemand wijs 
geworden.
9. Onderzoek doen is net als schoonmaken: het moet altijd even 
tussendoor, weinig mensen zien het resultaat en vaak is er al gauw 
iemand die het werk ongedaan maakt.
10. Als een rommelig bureau een rommelige geest weergeeft, lijkt de 
betekenis van een leeg bureau ook duidelijk (Albert Einstein).
11. Geluk is geen doel, maar een wijze van leven.
Nynke van Cruijsen 
Groningen, 24 mei 2006
Paranimfen: Hester van Cruijsen 
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H istorical background and pathogenesis
Menière’s disease was first described by Prosper Menière (1799-1862) who reported 
a clinical picture o f  patients with hearing loss, tinnitus and episodic vertigo 
accompanied by nausea, vomiting and syncope in the Gazette Médicale de Paris (1). 
Menière’s new concept that this mainly triadic symptomatology originated in the 
labyrinth instead o f being a vascular cerebral dysfunction brought him fame in the 
last year o f his life.
In 1938, Yamakawa and also Hallpike and Caims independently found 
hydrops o f the endolymphatic system (inner ear fluid system) in the temporal bones 
o f  deceased Menière patients (2;3). Endolymphatic hydrops has been the established 
histopathological origin o f  Menière’s disease since these findings. Lawrence and 
McCabe (1959) proposed the most accepted theory for endolymphatic hydrops 
generating episodic vertigo and fluctuating hearing loss (4). They suggested that 
distension o f  the endolymphatic compartment would lead to displacement and 
possibly rupture o f Reissner’s membrane. Consequently, an excess o f potassium- 
rich endolymphatic fluid leaks into sodium-rich perilymphatic fluid (the other inner 
ear fluid), which has neurotoxic effects on the sensorineural tissues.
The hydrops is thought to be caused by a disturbance o f the endolymphatic 
homeostasis through reduced absorption and temporary overproduction o f 
endolymph (5). It remains unclear how the exact mechanism for episodic increases 
in endolymphatic volume and the pathophysiology o f the symptom complex works. 
Nevertheless, many mechanisms for the reduced absorption o f endolymph have been 
proposed in a congenital or acquired dysfunction o f the endolymphatic sac. It has 
been shown that the endolymphatic sac and duet o f Menière patients were small 
compared to healthy Controls (6). The acquired dysfunction could be caused by a 
variety o f  factors as infections (bacterial or viral), immune-mediated aetiologies and 
vascular disorders (7). It seems more logical to conclude that Menière’s disease 
includes the classical triad and additional symptoms, which may be caused by 
multiple aetiological factors (Figure 1 (8)). No convincing scientific evidence is 
present to support any o f these hypothetical mechanisms (9).
Although the endolymphatic hydrops is the most commonly used 
pathophysiologic model, not every patiënt with endolymphatic hydrops experiences 
the clinical triad o f Menière’s disease (10). Endolymphatic hydrops is more a 
histological indicator for Menière’s disease than being directly responsible for its 
symptoms. Kiang mentioned in 1988 that endolymphatic hydrops could be an 
epiphenomenon in Menière’s disease (8). Creating acute endolymphatic hydrops in 
guinea pigs resulted in minimal effect on cochlear function (11). Nevertheless, 
repetitive endolymphatic hydrops may lead to biochemical disturbance o f  inner ear 
homeostasis. Hopefully, new imaging techniques (high-resolution functional 










Figure 1. Aetiological factors in Menière’s disease by Kiang (8).
Definitions
Menière’s disease has known many different definitions through the years. In 1972, 
the Committee on Hearing and Equilibrium o f the American Academy o f 
Ophthalmology and Otolaryngology defined Menière’s disease as being “a disease 
o f the membranous inner ear with characteristic symptoms and with a pathological 
correlate o f endolymphatic hydrops”. The American Academy o f Otolaryngology- 
Head and Neck Surgery (AAO-HNS) revised these definitions in 1985 and 1995 
(12; 13), see Table 1.
Parallel to this definition, in our clinic it was considered that the 
definition must include the clinical symptoms as the direct consequence o f  the 
idiopathic endolymphatic hydrops. After profound studies the “Definition Menière 
Groningen” was established by Mateijsen in 2001, see Table 2 (14). The diagnosis 
o f Menière’s disease is by exclusion o f other pathology, and makes thorough history 
examination very important for the correct diagnosis. The “Definition Menière 
Groningen” is used in this thesis for diagnosing patients with M enière’s disease.
11
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Table 1. AAO-HNS-criteria for the diagnosis of Menière’s disease (1995)
1. Recurrent, spontaneous episodic vertigo lasting at least 20 minutes (commonly several hours), 
often prostrating, accompanied by disequilibrium that may last several days; usually nausea, 
commonly vomiting or retching, no loss o f consciousness. Horizontal or horizontal rotatory 
nystagmus is always present
2. Sensorineural hearing loss (not necessarily fluctuating)
3. Either aural fullness or tinnitus (or both)
Table 2. Definition Menière Groningen (2001)
1. History o f at least two spontaneous vertigo attacks lasting longer than 20 minutes
2. Sensorineural hearing loss of at least 60 dB added up from the three worst octaves in the same 
ear, present or past
3. Tinnitus ipsi- or bilateral, present or past
Sym ptom s and epidem iology
M enière’s disease is characterised by the classical triadic symptomatology o f  
fluctuating, progressive hearing loss, periodic episodes o f rotatory vertigo and 
tinnitus. Sometimes this is accompanied by a sensation o f fullness or pressure in the 
ear (9). The symptoms do not necessarily portray themselves all at the same time. It 
can take months or years before all three or four symptoms are present and we can 
diagnose the patiënt with M enière’s disease. In general, the sensorineural hearing 
loss starts of as fluctuating in the lower frequencies and progresses to a permanent, 
flat audiometric pattem on all frequencies with loss o f speech discrimination. 
Tinnitus is either intermittently or constantly present. The vertigo appears suddenly 
and gives the sensation o f  a false movement. It seems as if  the surroundings are 
constantly spinning and moving around. Due to the perception o f rotating the 
patients often suffer from nausea and vomiting. During vertigo attacks the hearing 
loss usually increases and tinnitus intensifies. The unpredictability o f the vertigo 
attacks and the chronic character o f  the hearing loss and tinnitus make it a stressful 
and disabling disease.
There are two variations on the typical triad o f  Menière’s disease. Drop 
attacks occur in about 7% o f  the Menière patients next to their usual vertigo attacks
(15). They occur out o f the blue and last less than a second. Patients perceive that 
they are firmly pushed or drawn to the ground without loss o f consciousness. These
12
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drop attacks are thought to originate in the otolithic organs and are named the 
“otolithic crises o f Tumarkin” named after the British otologist Tumarkin in 1936
(16). They occur more common in patients with long-term Menière’s disease and 
during periods when the vertigo attacks are more frequent en intense. Lermoyez’ 
syndrome distinguishes from the classical Menière’s disease in hearing 
improvement around a vertigo attack (17). lts incidence is estimated about 1% of the 
patients with Menière’s disease.
The natural course of Menière’s disease is variable. The end-stage 
Menière’s disease is generally characterised by irreversible sensorineural hearing 
loss, continuous tinnitus with intermittent or chronic disequilibrium (18). It has been 
shown that up to 50% o f the patients will eventually develop symptoms in the 
opposite ear (19;20). Shea Jr and Filipo have both suggested a classification for the 
different stages o f Menière’s disease (21;22). These are mostly used in studies 
conceming natural course and investigating treatment modalities.
The incidence and prevalence o f  Menière’s disease differs widely for 
continents and countries. The prevalence o f  Menière’s disease has been estimated to 
range from 4 to 157 per 100,000, although this depends upon a number o f  factors, 
such as the diagnostic criteria used to define the disease (23). Based on these 
numbers it is estimated that there would be over 10,000 Menière patients in the 
Netherlands. Menière’s disease most commonly affects people in their 40's and 50's, 
although individuals from 20 onwards may be affected (24). It is rarely, though 
occasionally reported in children (25).
Treatm ent
There is no curative treatment available for Menière’s disease. Since the exact 
pathophysiologic mechanism remains unclear, every treatment remains 
symptomatic. The treatment options are medical and surgical. Many studies have 
been performed to test different medical treatment modalities, e.g. diuretics, 
antihistamines, sedatives, steroids and overpressure treatment. Betahistine and 
diuretics seem to be the only effective treatment options for long-term treatment o f 
vertigo (26). According to a Cochrane study in 2001, there was not sufficiënt 
evidence to state whether betahistine has any effect on Menière’s disease (27). 
Surgical procedures are executed in certain clinics when medical treatment fails. 
These invasive treatment modalities as endolymphatic sac surgery, vestibular 
neurectomy or labyrinthectomy are performed with different results (9). The less 
invasive intratympanic application o f steroids does not seem to alter 
symptomatology (28), although intratympanic aminoglycosides (gentamycin) do 
have an effect in reducing vertigo (29). It is acknowledged that the placebo-effect o f 
any treatment is large, namely 70-80% (30).
Nevertheless, Menière patients are not helped with the statement that no 
exact cause or curative treatment is available for their disease. So, every Menière 
patiënt needs individual treatment, wherein psychosocial help or even temporary 




M enière’s disease is a disabling disease with stressful symptoms: progressive 
hearing loss, tinnitus and sudden vertigo attacks. Idiopathic endolymphatic hydrops 
is thought to be the cause o f Menière’s disease, although compelling scientific 
evidence has never been given. It is estimated that there are over 10,000 Menière 
patients in the Netherlands. Since no Menière patiënt has similar exposition to or 
presentation o f symptoms, or perception o f disease, individual treatment is required. 
Psychological problems have to be taken into account and psychosocial help should 
be provided where needed.
Psychological aspects are often mentioned in the chronic and disabling 
Menière’s disease. In the following chapters a review o f this subject and o f general 
aspects o f stress are presented. Thereafter, the aims o f  this thesis are introduced in 
chapter 4.
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Menière’s disease is amongst the conditions in which psychological factors are often 
emphasised. Many physicians have reported accompanying emotional disturbances 
in Menière disease. Others have suggested that Menière patients have specific 
personality traits. These observations seem to have led to the conclusion that 
psychological factors could play a role in the development and continuation of 
Menière’s disease. Therefore Menière’s disease has received a lot o f  attention from a 
psychological point o f view.
The early literature on psychological considerations in Menière’s disease 
focussed on the psychosomatic causes and somatopsychic results o f the disease. A 
psychosomatic illness is defined as “a disease where the symptoms have an organic 
basis but the causes o f the illness are to be sought in psychosocial stressors and the 
inability o f  the patiënt to cope with stress”. This is in contrast with the 
somatopsychic theory, where psychological disturbances are due to physical 
complaints. The concept o f  an interaction o f both psychological and somatic factors 
in M enière’s disease has lead to more research in this field. The latest subject o f 
interest is the impact o f the disease on the daily life o f  Menière patients, the quality 
o f life. Since the latest literature reviews on psychological aspects in Menière’s 
disease were written in the 70s, a synopsis o f  the studies with this subject until now 
seems appropriate (31 ;32).
A chronological summary o f  studies on the psychosomatic, the somato­
psychic and both combined hypotheses in Menière’s disease is shown and reviewed 
in separate paragraphs. In an additional paragraph the studies conceming the impact 
o f M enière’s disease and their quality o f life are presented and discussed. At last, 
some suggestions for further research in this field are made.
Psychosomatic theory in Menière’s disease
In many reports psychological factors have been mentioned as aetiological or 
covariant factors in Menière’s disease by different researchers.
Fowler and his associates were the first to apply personality measures to 
patients with Menière's disease and proposed a psychosomatic aetiology for the 
condition. Fowler and Zeckel (1953) have done psychiatrie interviews and a series 
o f psychological tests in 23 patients with Menière’s disease (33). They concluded in 
this non-controlled study that the patients had different types of life stress and that 
they lacked an ability to cope with excessive tension. They stated that the emotional 
tension might precipitate the attacks. Their physiological explanation was that by 
sympathetic stimulation and release o f  adrenaline through the emotional stress, 
blood vessels in the labyrinth sludge (clotting o f cells and slowed blood flow), 
which subsequently causes the vertigo attacks.
In another study, Fowler and Appell (1956) compared the personality, 
physiques (somatotype) and otological diagnosis o f patients with Menière’s disease 
and patients with otosclerosis (34). They concluded that the body type o f  Menière’s
16
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patients as a group were more mesomorphic (athletic) and less ectomorphic (fragile) 
in the direction o f the perfectionist type, compared to the otosclerosis patiënt.
In a sequence o f  papers, Hinchcliffe (1967) examined the psychosomatic 
hypothesis in Menière’s disease from several perspectives (35-37). In the first study 
on emotion as a precipitating factor to disease, Menière patients (28/44) related their 
disease significantly more to emotional factors than otosclerosis patients (2/20) did. 
Next, he tested the personality profile o f Menière’s patients using the Minnesota 
Multiphasic Personality Inventory (MMPI). In this study was shown that 11 out o f 
44 Menière patients had a psychosomatic type o f  personality compared with none o f 
the 20 otosclerosis patients. This difference was significant. In the last study o f  this 
series, he used the same groups of people as mentioned above and their blood 
relatives, and added an unselected group o f hospital employees. He asked them all 
whether they had psychosomatic disorders (e.g. arthritis, migraine and peptic ulcer). 
The patients with Menière’s disease and their families reported more psychosomatic 
conditions than the otosclerosis patients and their relatives, and the employees. All 
the patients with Menière’s disease reported a history o f migraine and 11 (25%) 
reported cyclical vomiting of childhood. Hinchcliffe concluded that his findings 
enhanced a psychosomatic origin in Menière’s disease.
Siirala and Gelhar (1970) submitted Menière’s patients to a psychological 
interview and the Rorschach Inkblot Test (38). They found that these patients were 
overambitious, lacked insight and spontaneous affective responses to other people. 
They summarised their observations as evidence for a predisposing psychosomatic 
constitution for somatic complaints.
In 1975 Stephens published a paper titled “Personality tests in M enière’s 
disorder” (39). Stephens carried out this study using the Middlesex Hospital 
Questionnaire (MHQ) and the Eysenck Personality Inventory (EPI). The personality 
characteristics o f  104 Menière patients were compared with the personality 
characteristics o f 62 patients suffering from idiopathic peripheral vertigo, o f 170 
randomly selected ENT outpatients and with the mean values for the separate scales 
of the tests. The Menière patients had higher scores on anxiety, phobic anxiety, 
obsessionality, somatic preoccupations, depression and hysteria scales when 
compared to the normal Controls. When these patients were compared to the 
vertiginous patients they showed significantly higher obsessionality scores and 
depression scores. The scores for most scales decreased with increasing severity of 
the disorder, although the obsessionality scores did not follow this tendency. 
Stephens concluded that his results supported the earlier findings o f  Fowler (33;34).
In a study by Czublaski et al. (1976) 30 randomly chosen Menière patients 
were compared to 30 non-Menière ENT patients by means o f  a psychiatrie 
interview, the Maudsley Personality Inventory (MPI) and a 25-question Neuroticism 
Scale (40). In Menière’s disease various psychic stresses experienced in childhood 
were found to be more common. In 76.6% o f the cases the onset coincided with 
psychic conflicts and psychic stresses were found to intensify the symptoms in a 
high percentage o f  patients (60%). They feit that these results support the hypothesis 
o f a psychosomatic aetiology o f  M enière’s disease.
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Groen and Schmidt (1983) presented a study wherein 21 Menière patients 
were submitted to a biographical interview and a systemic psychosomatic follow-up 
(41). The group had a more or less specific personality structure; they had a high 
intelligence, great diligence and a great sense o f duty and they were to a great extent 
rigid and conscientious. Despite the absence o f a control group or a systematic data 
collection, the authors considered that these results confirmed previous indications 
o f the psychosomatic hypothesis o f Menière’s disease.
In summary, it seems clear that Menière’s disease is often associated with 
anxiety or other emotional problems. Most of the studies that favour the 
psychosomatic theory are based upon clinicians’ opinions and subjective reports of 
the patients. Many researchers used psychological tests without standardised 
psychometrie properties. One o f the problems with the reporting o f  (psychological) 
stress as precipitating factor is the retrospective reporting bias. This means that 
patients may selectively remember episodes o f stress and anxiety and wrongly 
perceive and describe themselves as having been abnormally anxious prior to 
developing vertigo. Another problem with most o f these investigations is that the 
symptom o f vertigo is not controlled for. Thus the emotional disturbance could be 
caused by vertigo rather than is the cause o f  the vertigo. Stephens (1975) has 
performed a well-constructed study in this field using vertiginous patients and other 
ENT patients as Controls (39). His conclusion that Menière patients do have more 
obsessionality traits and are more depressed than the Controls, justifies more 
research in this field. Nevertheless, the conclusion that Menière’s disease has a 
psychosomatic origin is dubious and needs at least more justification.
Somatopsychic theory in Menière’s disease
Researchers favouring the somatopsychic theory in Menière’s disease concluded 
that the psychological problems would be secondary to the inner ear disease.
Watson et al. (1967) were the first in line to support the somatopsychic 
theory more than the psychosomatic hypothesis (42). They compared the MMPI 
profiles o f 40 Menière patients and 38 non-psychogenic vertiginous Controls. The 
only significant between-group scale difference appeared on the hypochondriasis 
scale. Individual analysis provided only weak support for the psychosomatic 
hypothesis. They concluded that this could be attributed to the physical 
symptomatology o f  the disorder and gives minimal evidence for the general 
psychosomatic hypothesis.
In a neuropsychological study by Löchen (1970), 30 Menière patients were 
compared with a group o f 50 patients with verified severe cerebral atrophy (43). 
Among other things, they were individually examined with a set o f psychological 
tests and underwent neurological examinations. He showed that the more serious the 
intellectual impairment was, the higher was the incidence o f organic lesions judged 
from neurological signs, otological, EEG and pneumo-encephalographic 
examinations. Therefore, he supported the hypothesis that the psychological 
disturbances in Menière’s disease are secondary to an organic disorder.
18
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Pulec (1972) presented the results o f  a two and one-half year study of 
aetiology, natural course and results o f  treatment (44). He performed a 
psychological investigation using the MMP1, an anxiety scale, a self-esteem scale, a 
psychosomatic checklist, a personal stress questionnaire and an interview by a 
psychologist. The results lacked evidence regarding involvement o f emotional 
factors in the aetiology o f  this disease. But, continued evaluation suggested that 
patients already suffering from a vertiginous problem would sometimes have an 
exaggeration o f symptoms during periods o f stress. They explained this observation 
by two causative factors. Firstly, stress and fatigue are thought to reduce the 
effectiveness o f the vestibular efferent system and its suppressing effect upon a 
malfunctioning inner ear. When suppression is reduced, the existing abnormal 
labyrinthine stimulation becomes evident. Secondly, Menière patients are on the 
border o f control and have inadequate adrenocortical output during periods o f stress 
with subsequent exaggeration o f symptoms.
In the year 1975, Brightwell and Abramson tested 13 patients with 
Menière’s disease, 18 non-Menière vertiginous patients, patients with otosclerosis 
(n=13) and patients with lymphoma (n=12), using the EPI and the Comell Medical 
Index (CMI) (45). The groups did not differ from each other in their personality test 
mean scores. Numerous correlations were found between personality scores and 
symptom severity within the Menière group. The authors suggested a subgroup of 
Menière patients who may have significant emotional factors involved in their 
illness and that psychological vulnerability might be a useful concept.
Crary and Wexler (1977) constituted a new approach to the question 
whether the data used to support the psychosomatic hypothesis is actually evidence 
of a somatopsychic process (31). In their study four groups were compared: 63 
Menière patients, 15 Menière patients (cross-validation group), 33 non-Menière 
vertiginous patients and 17 non-vertiginous ENT patients. They conducted a 
comprehensive investigation to examine the development, onset, course and 
outcome in Menière’s disease. The patients were followed for 2 years with many 
questionnaires regarding severity o f  the disorder, stress preceding the disorder and 
personality. A random subsample o f 20 Menière patients recorded the presence or 
absence o f life stress, tinnitus and vertigo on a daily diary sheet. No clear-cut 
differences were found when Menière patients were compared to vertiginous 
patients on psychological variables conceming development, onset, course or 
outcome o f the disease. Parallel to the clinical study on the psychosomatic 
hypothesis, they analysed the literature relating psychological aspects to Menière’s 
disease, vertigo and tinnitus. According to them, most o f  the clinical studies 
revealed a variety o f methodological flaws: simple case reports, no use o f  objective 
measurement techniques, no appropriate statistical tests or no control groups. They 
concluded that it could not be ruled out that psychological stress may play a 
developmental and/ or precipitating role, but that on the basis o f current available 
research designs and instruments, the best evidence indicates that the effects are 
somatopsychic. In 1980 House, Crary and Wexler presented the same results and
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conclusions o f  their 1977 study at a Symposium on Menière’s disease and 
subsequently in another paper (16).
Hereupon, Hinchcliffe (1983) argued from a variety o f measures that the 
classical Menière patients and the patients with primary vertigo are merely on 
different parts o f  the same continuum, making comparison between these groups 
somewhat questionable (46). In 1986, Wexler and Crary reiterated their standpoint 
as made in the paper o f  1977 and emphasised the question o f what constitutes a 
psychosomatic disorder (47). They stated that any research on psychological factors 
in M enière’s disease should also address this question. The conclusion o f Crary and 
Wexler (1977) was also challenged by Jakes (1987), who pointed out that several 
aspects o f  the data were not considered, e.g. the occurrence of stress without vertigo 
attacks (48). Jakes also stated that the patients’ discomfort from the disease might 
also cause stress and fatigue.
In neuro-psychological studies by Sorensen et al. (1977) and Zilstorff et al. 
(1979) Menière patients were subjected to a battery o f neuro-psychological tests (20, 
21). They demonstrated that patients with longstanding Menière’s disease had 
psychological disturbances, presumably localised in the non-dominant hemisphere. 
In short-duration Menière’s disease these results could not be replicated. It is 
concluded that the central changes in the non-dominant hemisphere function develop 
over a longer period o f  time.
In 1984 Rigatelli et al. examined 60 patients with vertigo by means o f  a 
biographic interview and o f three self-rating scales (MHQ, Zung’s Self-rating 
Depression Scale and Anxiety Scale) (49). The patients were divided into groups: 
Menière’s disease (n=8), neuronitis (n=14), vertebrobasilar insufficiency (n=16), 
sensorineural deafness (n=8) and nucleoreticular syndrome o f Ararslan (n=12). The 
other two patients had respectively inner ear lithiasis and damage of the labyrinth 
after stapedectomy. The control group was composed of 60 ENT patients with non- 
vertiginous and non-surgical pathology. The comparison between the vertiginous 
patients and the control subjects showed significant differences in depressive state, 
anxiety, somatisation and total neuroticism. The patients affected by M enière’s 
disease showed no significant differences regarding depressive symptomatology and 
anxiety, when compared with the other vertigo sufferers. On the other hand, Menière 
patients had statistically lower indices on obsessional traits and higher levels of 
somatisation compared to the sum o f the other disease groups. They concluded that 
vertigo syndromes need a strict collaboration between psychiatrist and the 
otorhinolaryngologist.
Grigsby and Johnston (1989) presented two cases o f women with Menière’s 
disease who also experienced concurrent feelings o f  depersonalization and 
derealization (23). They argued that emotional disturbances previously identified as 
predisposing causes o f Menière’s disease are more likely effects o f  the disease.
In summary could be said that the researchers favouring the somatopsychic 
theory did perform better constructed studies than the ones who supported the 
psychosomatic hypothesis by using vertiginous Controls. Although the evidence for 
the somatopsychic theory is stronger than the psychosomatic hypothesis, it is not
20
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waterproof. Emotional factors do seem to play more o f a role in subgroup of 
Menière patients. Nonetheless, a correlation between emotional factors and a vertigo 
attack could never be scientifically proven for every Menière patiënt. This difference 
in psychological problems in Menière patients could be explained by individual 
differences in psychological vulnerability and coping. The psychological 
disturbances can not exclusively be explained by physical factors. There seems to be 
no straight answer to the question whether the psychological problems are 
psychosomatic or somatopsychic. Both theories could not be proven solidly. It 
suggests reciprocity o f  psychological and somatic factors in the continuation o f 
Menière’s disease.
Reciprocity of psychological and somatic factors in Menière’s disease
After three decades o f studies based upon the psychosomatic and somatopsychic 
theories in Menière’s disease, it was concluded that once the disease has appeared, 
psychological and somatic factors interact. This is parallel to the general 
consideration o f  psychosomatic diseases developed through the years.
Coker et al. (1989) examined the psychological profiles o f  21 patients with 
active Menière’s disease and 27 patients with inactive Menière’s disease using the 
MMPI and the Diagnostic Inventory o f Personality and Symptoms (DIPS) (50). The 
differentiating factor for active versus inactive disease was the presence o f  vertigo or 
disequilibrium in the past 3 months. In this study, depression was clearly the 
significant diagnosis seen in individuals with active Menière’s disease, compared to 
the normal values of the separate tests. The MMPI classified 80% o f the active 
(n=20) and 32% o f the inactive group (n=25) as depressed and the DIPS classified 
70% o f the active (n=20) and 39% o f the inactive Menière patients (n=23) as 
depressed. The authors concluded that psychological assistance and possibly anti- 
depressant medication may be beneficial to the patiënt as an adjunctive treatment for 
Menière’s disease.
In 1991 Martin et al. assessed 45 Menière patients with the Symptoms 
Checklist (SCL-90) and 37 Menière patients with the French “Questionnaire 
Depression” (QD2) (51). It appeared that Menière patients have significantly more 
psychopathological disorders than “normals”, namely anxiety, depressive tendency 
and phobia.
A study titled “Illness behaviour, personality traits, anxiety, and depression 
in patients with M enière’s disease” was presented by Savastano et al. in 1996 (52). 
50 Menière patients were psychologically tested with the Illness Behaviour 
Questionnaire (IBQ), EPI, State Trait Anxiety Inventory (STAI), and the Zung’s 
Self-Rating Depression Scale. They found higher neuroticism scores, more 
markedly psychological perception o f  the disease and a lower level o f  affective 
inhibition than normal. Anxiety and depression scores were not significantly higher 
than normal. Cluster analysis o f  the IBQ scores identified subgroups o f  Menière 
patients with normal scores and with severe psychological distress. Patients from the 
latter group were older and had a longer history o f  Menière’s disease and more
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hospital stays. Savastano et al. concluded that their results indicate the possibility o f 
distinguishing those patients whose personality traits could facilitate the 
development o f abnormal illness behaviour and psychological symptoms in relation 
to Menière’s disease.
Erlandsson et al. (1996) did a “focus group interview” with four Menière 
patients and a semi-structured interview with another four patients with Menière’s 
disease (53). It was reported that attacks were triggered by distressing thoughts and 
by sensory sensations.
Sawada et al. (1997) studied the psychosomatic profile o f Menière patients 
in relation to their plasma anti-diuretic hormone (p-ADH) concentration (54). 
Psychological aspects were tested using the Comell Medical Index (CMI) and the 
Yatabe-Guiltford personality test in 34 patients. The CMI showed significantly more 
subneurosis and neurosis types than “normals”, but this was not related to p-ADH 
levels. The personality test classified the patients with Menière’s disease in the 
normal range. In a self-constructed stress questionnaire another 46 patients were 
asked if  they have had stress before vertigo and what kind o f stress it was. 78% of 
the 46 patients were conscious about stress before an attack and they had a 
significantly higher p-ADH level than the patients without stress.
Andersson et al. (1997) presented a time-series analysis o f  stress and 
symptoms o f Menière’s disease (55). Twenty Menière patients reported daily on 
four visual analogue scales from “none at all” to “the maximum possible” about 
discomfort o f dizziness, tinnitus, hearing problems and experienced stress. 
Concurrent associations between stress and symptoms o f Menière’s disease were 
found, particularly in relation to vertigo. However, this study did not support the role 
o f stress as a precursor o f symptoms in Menière’s disease.
In another study Hagnebö et al. (1998) investigated the premonitory 
sensations o f  Menière attacks in 514 patients (56). They developed three scales for 
measurement o f  somatic (SOM) and psychological (PSYCHOL) sensations and of 
situational (SIT) characteristics, surrounding an attack o f Menière’s disease. 
Principal components factor analyses showed that the SOM scale could be divided 
into two subscales: dizziness/vertigo/anxiety and sensations in the ear. The 
PSYCHOL scale showed an energy/awareness factor and a negative emotional state 
factor. The SIT scale showed the two factors environmental disturbances and 
stressful conditions. The authors concluded that knowledge o f  somatic, 
psychological and situational premonitory characteristics o f attacks in Menière's 
disease could lead to improved therapy and counselling.
Takahashi et al. (2001) devised a questionnaire to analyse lifestyle and 
behavioural characteristics in Menière patients (57). The Menière patients (n=60) 
compared to 936 healthy Controls had a significant more stress-causative tendency in 
behavioural characteristics, feit stronger anxiety and showed more severe symptoms 
owing to this anxiety.
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Handicaps and quality of life in Menière’s disease
Recently there has been a strong push toward outcome-based research in medicine to 
assess the results o f treatments. Important elements in the outcome-based research 
are the issues o f  handicap and quality o f  life. This trend is also seen in studies 
conceming Menière’s disease.
The International Classification o f  Impairments, Disabilities and Handicaps 
(ICIDH) was first published by the World Health Organisation (WHO) in 1980. The 
original goal o f  the ICIDH was to provide a framework to organise information 
about the consequences o f diseases in terms o f resulting impairments, disabilities 
and handicaps. Impairment refers to the loss o f physiologic function, such as hearing 
loss. Disability refers to the loss o f function caused by the impairment, such as the 
inability to use verbal language because o f  the hearing loss. Handicap refers to the 
social effects o f disability, such as the inability to converse with co-workers owing 
to hearing loss. In 1995 the WHO Quality o f Life group defïned the concept 
“Quality o f  Life” as the individuals’ perception o f their position in life in the context 
o f culture and value system in which they live and in relation to their goals (32). The 
quality o f  life is divided in three separate domains: physical, psychological and 
environmental. The physical component o f quality o f life refers to physical effects 
o f the disease: pain, fatigue or vertigo. The psychological domain is related to an 
individual’s mood in a global sense, e.g. fear or depression. The environmental 
component o f quality o f life has two important elements: social participation and 
role activities. The interaction between the disabling process and quality o f  life is 
presented in Figure 1 (32, 33).





Quality o f life
Figure 1. Disabling process and quality o f life.
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The studies mentioned in this paragraph were more concemed with the 
seriousness o f  the psychological disturbances. Anxiety and depression are common 
problems in Menière’s disease. It seems clear that the possible consequences of 
vertigo might be frightening. The acute vertigo attacks are infrequent, unpredictable 
and violent. The patients try to avoid the attacks and tend to impose restrictions on 
their activities and lifestyle, which may generate further feelings o f  helplessness and 
depression. In many retrospective studies psychological stress was a precipitating 
factor in aggravating the disease. But a correlation o f stress and the development of 
a vertigo attack could not be shown in the only prospective study presented by 
Andersson et al. (1997) (55). On the basis o f  the most recent research, it cannot be 
ruled out that psychological stress might play a precipitating role in Menière’s 
disease, but its more likely that the psychological picture is a result of, and not 
specific to this illness. It may rather express an individual’s generalised 
vulnerability.
As a result o f a chronic condition, like Menière’s disease, life will change 
considerably. Just a few studies have dealt with disability factors, influences on the 
daily life o f patients and their experience o f the quality o f life.
The first published study on Menière’s disease and quality o f life came 
from Cohen et al. in 1995 (58). Data conceming disability in Menière’s disease were 
analysed from 51 Menière patients who filled in a self-administered questionnaire. 
They found that vertigo is the most bothersome symptom influencing a subject’s 
performance at work, followed by hearing loss. Their results also pointed out 
individual differences in coping with the symptoms.
Hagnebö et al. (1997) devised a questionnaire to investigate the influence 
o f  vertigo, hearing impairment and tinnitus on the daily life o f 514 Menière patients 
(59). The results indicated that the three key symptoms had a strong negative effect 
on the daily life o f Menière patients. 75 percent o f the subjects avoided certain 
everyday activities or situations because o f  the disease. More than half o f  them 
stated that they never feit free o f  discomfort from the illness. The subjects reported 
most discomfort from the tinnitus; this is in contrast with the findings o f Cohen et al. 
(58). This may be explained by the fact that vertigo is a symptom o f a temporary 
nature and that discomfort from tinnitus and hearing impairment seems to increase 
the illness span. All the same, no significant relations were found.
Kinney et al. (1997) evaluated the long-term hearing results and quality of 
life in patients with Menière’s disease (60). Two groups o f  Menière patients were 
compared using audiometric tests, disease-specific quality o f  life tests (Hearing 
handicap inventory, Dizziness handicap inventory and Tinnitus handicap inventory) 
and a more general quality o f  life measure (SF-36 health survey). One group (n=31) 
was medically treated and the other consisted o f  20 surgically treated patients. No 
significant differences were observed for long-term audiometric data for either 
group. This suggests that long-term hearing results are not altered by medical or 
surgical treatment. Since there were no significant differences between the treatment 
groups in the disease-specific handicap scales and in the global health scale, data 
were analysed as one group (n=51). More than three-quarter of the patients reported
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that hearing loss, dizziness and/or tinnitus affected their quality o f  life to some 
degree. Patients with Menière’s disease functioned more like patients with minor 
medical conditions on the physical function, role limitations due to physical 
problems, bodily pain and general health perceptions. In contrast, Menière patients 
functioned more like patients with major medical conditions for the vitality, social 
function, and role limitations due to emotional problems. These findings suggest that 
the underlying emotional component o f Menière’s disease is more handicapping 
than the physical components are.
Murphy and Gates (1999, 2000) reported the development o f  two clinically 
useful methods to quantify the morbidity o f Menière’s disease: the Menière's 
Disease Patient-Oriented Severity Index (MD POSI) and the daily vertigo diary card 
(37, 38). The MD POSI could be a useful disease-specifïc outcome instrument, but 
will be revised and further evaluated and validated.
In 2001 Söderman et al. presented a study with subjective evaluations o f 
quality o f  life related to disease specific symptoms, sense o f coherence and 
treatment in Menière’ disease (61). 112 patients with Menière’s disease were split 
up in three groups: endolymphatic sac surgery (n=59), intra-tympanic gentamycin 
injections (n=26) or surgically untreated (n=27). All patients were measured with the 
Vertigo symptom scale, Hearing disability handicap scale, Tinnitus ,severity 
questionnaire, the AAO-HNS criteria for reporting results o f  treatment o f  M enière’s 
disease and the Sense o f  Coherence scale. There was no difference in general quality 
o f life, present hearing loss or tinnitus between the three treatment groups, but the 
gentamycin-treated patients had less vertigo than did the other groups. Sense of 
coherence showed a strong correlation to reported quality o f life in all 
measurements.
Anderson and Harris (2001) studied the impact o f  Menière’s disease on the 
quality o f  life using several general health measures (Quality o f  Well-being Scale, 
SF-12 physical and mental scores and a Depression scale) (62). 19 Menière patients 
who requested for further treatment got pre-treatment interviews to establish 
baseline quality o f life characteristics before medical intervention. The results 
indicated a loss o f  well being compared to people with no symptoms and full 
functional status. Furthermore, the Depression scale indicated a clinically significant 
depression in Menière patients.
In general, disability in Menière’s disease is difficult to quantify. Three of 
the four symptoms are subjective, with hearing being the most quantifiable o f  the 
symptom complex. Another factor, which makes the disability difficult to determine, 
is the fluctuating, unpredictable nature o f  the Menière’s disease process. This 
complicates giving the employers and insurance companies o f the Menière patients 
exact data how much the Menière patiënt is disabled. Nevertheless, it seems clear 




Future of psychosocial research in Menière’s disease
The psychosomatic theory is not adequate enough to be the exclusive aetiological 
cause for Menière’s disease. Although a somatopsychic factor seems evident, it is 
not the sole explanation. The best way to interpret this complex process seems to be 
a continuous interaction o f psychological, somatic and environmental factors. It is 
opted and very likely, that the process is becoming a vicious cycle: symptoms o f the 
disease could worsen the emotional state, which in turn could worsen the 
(perception of) symptoms.
Nevertheless, the question “Which came fïrst, the hen or the egg?” remains 
unsolved. Since it is not feasible to have the personality profile or other 
psychological measures before the disease has developed, we’11 presumably never 
know the answer. But that is probably irrelevant: more important is to know how the 
emotional and physical factors interact exactly and why one person develops more 
frequent and more severe chronic problems after getting Menière’s disease than the 
other. However, o f the utmost importance is the question how we can interfere in 
this suggested vicious cycle o f physical symptoms and emotional or environmental 
disturbances and help these patients.
To get these answers, the suggested reciprocal process has to be studied in a 
prospective design. Firstly, the process has to be put in a general model o f stress 
with stressors (physical symptoms and psychological disturbances), appraisal 
(coping and personality) and stress responses (psychological, physical and 
behavioural). In this multifactor model, the separate psychological, somatic and 
behavioural aspects o f  Menière’s disease all have their specific place in the model 
and interrelate. O f course, the impact o f  the disease, the quality o f life, plays an 
important role in this model. Not only as an endpoint measurement o f general 
impact o f the disease, but also as a possible stressor in the process. All together, 
these factors interact in a vicious cycle. Every single factor in the model has to be 
qualified and quantified by means o f validated, standardised measures containing 
the appropriate psychometrie properties. Information about this process and its 
factors might give us better insight in which Menière patiënt and in what way 





As suggested in the preceding chapter, Menière’s disease may develop into a vicious 
cycle o f physical and psychological factors that can be put in a universal model o f 
stress with stressors and stress responses.
In this chapter aspects o f stress in general and their relation to disease are 
presented. Firstly, it is used to present the background and aims o f this thesis. 
Secondly, it allows us to expose the definitions as used in this dissertation. It 
includes old and new facts about stress, as well as the effects o f  stress and stress 
hormones upon bodily systems and organs, healthy ears and Menière ears.
General aspects of stress
Stress has been a subject o f  interest among many researchers who are studying 
environmental and psychosocial influence on health for a long period o f  time. 
Historically, the first description of stress was by Cannon in 1932, who defined it as 
the systemic stress that causes disturbances o f the tissue system (63). He observed 
that a pattem o f physiological mobilisation was elicited during times o f arousal, 
which he described as the “fïght and flight response”.
In 1956 Selye defined the General Adaptation Syndrome as “the sum o f all 
non-specific, systemic responses to the body that ensues upon sustained exposure to 
stress” (64). This syndrome generally develops through three stages o f pathological 
and biochemical changes: the alarm reaction, the stage o f resistance and the phase o f 
exhaustion. Selye’s model has been very influential, but it has also been critiqued 
for underestimating the role o f psychological factors in stress, such as a person’s 
emotional state or the way a person thinks about stressors.
This led to the development o f  a psychobiological model, the transactional 
model, by Lazarus and Folkman (65). In this model the stress response depends on 
the evaluation o f  the stressor, called appraisal. They proposed that a stress response 
is elicited if  an individual appraised a potentially stressful event as stressful. 
Appraisal depends on the received characteristics o f  the stimulus and the 
psychological structure o f  the individual (primary appraisal) or on the individual’s 
coping style (secondary appraisal).
Still, the definition o f the term “stress” lacks conformity and it is not used 
very consistently. Researchers in this field use the term “stress” variably as the event 
(stressor) or the reaction (stress response). Cohen et al. properly summarised the 
stress process in the following way: “environmental demands tax or exceed the 
adaptive capacity o f an organism, resulting in psychological and biological changes 
that may place people at risk o f disease” (66). The stress response is a reaction to a 
stressor and its evaluation is split up into three separate reactions, namely 
psychological, physiological and behavioural.
The psychological stress response is defined as the effect on the emotional 
state. In the acute situation this could be fear and anger. If stressors persist for a 
longer period o f  time or occur in rapid succession, people do not have time to
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recover from this situation. This situation may lead to a state o f tension, irritation or 
depression.
The physiological stress response is the effect of the stressor on the 
physiological balance o f  the body, the homeostasis. The physiological stress 
response results in more glucocorticosteroid and catecholamine secretion. The 
physiological response and the stress hormones are discussed in detail in paragraph 
“Stress and stress hormones”.
Stress reactions become clear in the way people look, act or talk in the acute 
situation. Strained facial expressions, tremors or a trembling voice are common 
behavioural stress responses. In the long run, people develop ways to avoid the 
stressors, for instance giving up jobs or education, abusing alcohol or even 
attempting suicide.
In this work, the stress process has been divided into specific components as 
Cohen et al. did namely stressors (potentially threatening events or situations), 
appraisal (perception o f stress) and the stress response (instinctive, behavioural and 
biological responses on stressors or appraisals). Whereas the term “stress” is used 
exclusively for situations that the individual interprets as threatening and causes 
some physiological, affective and behavioural responses.
New terms: allostasis and allostatic load
Due to problems defining the concept o f “stress” and o f  quantifying it 
psychologically and physiologically, two new terms have been formulated: allostasis 
and allostatic load. Allostasis means literally stability through change. In 1988 this 
term was introduced by Sterling and Eyer to describe the adjustment o f  the 
cardiovascular system to the bodily state, in rest or in strain (67). This regulation can 
be ascribed to physiological mediators such as cortisol and catecholamines.
McEwen defined allostasis as “the ability o f  the body to increase or decrease 
vital functions to a new level within that range upon challenge, particularly in 
anticipation o f a challenge” (68). Whenever the brain considers an event as 
threatening (stressful), physiological and behavioural responses are generated. These 
responses lead to allostasis and adjustment. In this process the stressor is everything 
which brings the body out o f balance and the stress response is the physical reaction 
to restore the balance by secretion o f hormones.
The term “allostatic load” refers to an overload o f  the body. It is the price 
the body has to pay for constant allostatic reactions to psychosocial or physical 
situations. It involves damaging effects o f continuously increased secretion of 
catecholamines and glucocorticosteroids. This allostatic load may lead. to wear and 
tear o f organs and tissues, and make individuals more susceptible to illness.
In the cardiovascular system the catecholamines are needed for adjustment of 
the pulse rate and blood pressure during different situations such as sleeping, 
awakening and physical exertions. Frequent increases in blood pressure during stress 
or a failure to stop this increase o f  pressure accelerates arteriosclerosis. Adrenal 
hormones cause allostasis by the extra intake of food and the use o f  the energy
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reserves. Recurrent stress brings on insulin resistance and accelerated progression to 
diabetes mellitus type 2, including obesity. While acute stress activates the immune 
function, chronic stress suppresses the immune system. Subsequently, suppression 
o f  the immune system makes an individual more susceptible to infection and 
inflammation. In the brain catecholamines and glucocorticosteroids are related to the 
preservation o f both positive and negative emotional memories. During frequent and 
chronic increases o f glucocorticosteroid levels, the memory function o f  the brain 
declines through hippocampal atrophy (see paragraph “Glucocorticosteroids and 
hippocampus”).
Stress and stress hormones
In this paragraph the current view on the physiological response during stress is 
presented. The physiological stress response elapses through two systems, namely 
the hypothalamic-pituitary-adrenal (HPA) axis and the autonomie nervous system 
(ANS). During stress the hypothalamus releases more corticotrophin releasing 
hormone (CRH) and antidiuretic hormone (ADH). The CRH activates the pituitary 
gland into producing more adrenocorticotropic hormone (ACTH), which stimulates 
the adrenal cortices to secrete more glucocorticosteroids (cortisol) and 
mineralcorticosteroids (aldosterone). Secondly, stressors activate the sympathetic 
branch o f  the ANS, which stimulates the medullae o f the adrenal glands to secrete 
more catecholamines, namely adrenaline and noradrenaline.
Cortisol
Cortisol is a potent glucocorticosteroid (GC) that affects the metabolism of 
carbohydrates, proteins and fats. It has a profound effect on glucose serum levels. 
Cortisol tends to increase glucose by stimulating gluconeogenesis from glucose 
stores and inhibits glucose transport into cells. There are three mechanisms o f neuro- 
endocrine control for cortisol secretion (69). The first is the circadian rhythm and 
episodic secretion o f  ACTH. Cortisol secretion is at its highest level in the early 
moming, approximately one hour before waking up, which declines again as 
wakefulness occurs. Cortisol levels then gradually diminish during the day and 
night, but cortisol secretion increases in response to eating and exercise. Although 
this pattem is consistent, there is considerable intra- and inter-individual variability, 
and the circadian rhythm may be altered by changes in sleep pattem, light/ dark 
exposure and eating times. Another neuro-endocrine control for cortisol secretion is 
the stress responsiveness to physical stress (illness, starvation) and psychological 
stress (anxiety, depression). Stress responses originate in the central nervous system 
and increase hypothalamic CRH and thus pituitary ACTH secretion. The third 
mechanism is the negative feedback o f cortisol on the hypothalamus and pituitary. 
With continued cortisol secretion, ACTH levels continue to decrease and become 
unresponsive to stimulation with CRH.
Cortisol circulates bound to plasma proteins. The plasma half-life of 
cortisol is around 80 minutes and is determined by the extent o f plasma binding and
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by the rate o f metabolic inactivation. In basal conditions approximately 75% o f the 
cortisol is bound to corticosteroid-binding globulin (CBG), around 10% is unbound 
(free) and the remainder is bound to albumin. Synthetic glucocorticosteroids such as 
prednisolon are bound to albumin.
Analysis o f plasma cortisol is predominantly done with radioimmunoassay 
(RAI), which measures the total, bound and free cortisol (70). Cross-reactivity with 
some synthetic glucocorticosteroids is variable. Normal values o f plasma cortisol 
concentration demonstrate a circadian rhythm. The highest concentrations range 
from 200-800 nmol/1 and are seen in the early moming. Urinary free cortisol is 
measured from a 24-hour urine collection by RAI. Less than 1% o f the secreted 
cortisol is excreted unchanged in the urine. This method is particularly useful in 
differentiating obesity from Cushing’s disease. The normal range o f urinary free 
cortisol is 20-270 nmol/24h.
Dexamethasone is a potent glucocorticosteroid and normally suppresses 
pituitary ACTH release with a fall in plasma and urine cortisol as a result. This fact 
is used in the dexamethasone suppression test (DST), where 1 mg dexamethasone is 
administrated as a single dose at 11:00 PM and the following moming a plasma 
sample is obtained for cortisol measurement. The inhibition feedback is abnormal 
when the cortisol level is above 50 nmol/1, which is mostly present in patients with 
Cushing’s disease. False negative results are rare, but may occur in patients whose 
dexamethasone metabolism is slow. On the other hand, false positive results occur in 
15% o f patients with obesity and 25% o f hospitalised and chronically ill patients. 
Acute illness, depression, anxiety, alcoholism, high-oestrogen states and uraemia 
may cause false-positive results (70).
A relatively new development is the measurement o f cortisol in saliva. lts 
foremost advantage over plasma cortisol is obtaining material without stressful or 
invasive procedures such as venipunctures. Saliva is obtained using a Salivette 
cotton swab (Sarstedt, Nümbrecht, Germany) under the tongue for a few minutes. 
Normal values with the competitive protein-binding assay at 8:00 AM are 16 ± 1.7 
nmol/1 for men with a range o f 6.4 to 32 nmol/1, and 9.8 ± 3.1 nmol/1 for women 
with a range o f 4.8 to 18 nmol/1 (70).
Catecholamines
The adrenal medullae are ordinarily activated during ANS arousal, and subsequently 
they release adrenaline and noradrenaline into the circulating system. The effects of 
catecholamines are seen in the cardiovascular system, such as an increase of 
frequency and force o f  the contraction o f the myocardium and the contraction o f  the 
vascular smooth muscle. Overall, this leads to an increase o f  blqod pressure. 
Catecholamines also have effects on relaxation and/ or contraction o f some 
extravascular smooth muscles, e.g. uterus, intestine, bladder, sphincters, trachea and 
pupils. Furthermore, catecholamines increase oxygen consumption and heat 
production. They also regulate glucose and fat mobilisation from storage depots.
Circulating levels o f catecholamines can be measured by assaying blood 
samples, but the half-lives o f adrenaline and noradrenaline are very short (1-3
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minutes), and the tumover or decay o f the circulating levels can occur within two 
minutes. Adrenaline and noradrenaline blood levels fluctuate and vary intra- 
individually considerably, which is not particularly useful in studying chronic stress. 
Measurement o f  urinary adrenaline and noradrenaline or their metabolites provide 
longer, more stable indices o f  ANS activity than do blood measures. For studies of 
ambient or chronic stress, 24-hour urine samples are traditionally used. Normal 
values for urine adrenaline range from 0.1 to 10 fitn/mcrea and noradrenaline 
between 0.1-30 |am/mcrea.
Glucocorticosteroids and hippocampus
The hippocampus (Greek for seahorse) is a compact structure in the brain lying 
posterior from the amygdala. It consists o f gray matter (Ammon’s hom and dentate 
gyrus) and white matter (alveus and fimbriae). The term hippocampus has to be 
distinguished from the hippocampal formation, which includes the Ammon’s hom, 
dentate gyrus, subicular complex and entorhinal cortex. The two hippocampi are 
located in the temporal lobes and lie on the medial floor o f the temporal hom o f the 
lateral ventricle (Figure 1).
Figure 1. Sagital view of the brain
The role o f the hippocampus in memory has long been appreciated. More 
recent reports have suggested that a functional hippocampus is needed for a specific 
cognition process termed declarative, explicit or relational memory. Another 
function o f the hippocampus is to provide a negative feedback to the HPA axis (71). 
The hippocampus is a primary central nervous system target for glucocorticosteroids 
and it is a highly plastic and vulnerable region o f the brain. In the short term a stress- 
induced increase in catecholamines and glucocorticosteroids facilitates saving 
emotional events. Though, repeated stress with high glucocorticosteroid levels and 
an overactive release o f  excitatory neurotransmitters cause shortening and 
debranching o f  the dendrites in the Ammon’s hom and suppresses neurogenesis of 




information processing and memory loss, as well as elevated plasma levels o f CRH, 
ACTH and cortisol.
Signs o f  hippocampal damage including HPA axis dysregulation and 
memory impairment are found in affective disorders (73;74), Cushing’s disease 
(75;76), human aging (77), Alzheimer’s disease (78) and in posttraumatic stress 
disorder (79). The reduced hippocampal volume in these conditions was shown on 
magnetic resonance imaging scans (Figure 2).
Figure 2. Hippocampus (in white) on MRI scan
Effect of stress and stress hormones on the ear
During stress many changes in cognitive and sensory skills appear. According to 
Sapolsky, certain aspects o f  memory improve and the detection o f sensations is 
better during stress (80). Some obscure mechanisms are supposed to make the 
sensory receptors more sensitive. The cochlear cells o f the human ear need less 
stimulation under moderate stress in order to be stimulated and to process the 
information to the brain. Sapolsky’s statement seems to have no scientifïc 
foundation and has never been underlined by others. Studies concemed with the 
effects o f stress and its hormones in both animal and human ears will be presented in 
this paragraph.
Effect o f  stress and stress hormones on the animal ear
Several animal studies have been performed on auditory functioning, stress and 
certain stress hormones (catecholamines, mineralcorticosteroids (MCs) and 
glucocorticosteroids (GCs)).
Muchnick et al. have mainly focused on the effects o f  stress and 
catecholamines on the hearing thresholds (81;82). Guinea pigs under stress had to be 
given a louder stimulus than to the ones without stress to get the same response. 
Furthermore, vasoconstriction o f  the labyrinthine blood vessels induced by 
adrenaline reduced the cochlear blood flow and increased the mean action potential
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threshold with 11 dB. They gave two explanations for these findings. Firstly, the 
increased cochlear action potential threshold induced by a stressfïil situation creates 
a new level o f  responsiveness o f  the auditory receptors to a certain sound pressure 
level. The stressed guinea pigs probably have a higher receptor response level, 
which causes less threshold shifting compared to sedated guinea pigs. The second 
option is thought to be associated with changes in cochlear blood flow. The cochlear 
function may be partly determined by the difference in the magnitude o f two forces: 
vasoconstriction o f  the cochlear vessels which tends to decrease the cochlear blood 
flow and increased systemic blood pressure which tends to overcome this difficulty.
In a study by Juhn et al. was shown that adrenaline infusion in chinchillas 
increased the osmolality in serum and perilymph and significantly elevated the 
compound action potentials for all frequencies (83). Continuous infusion with 
adrenaline (max. 4 weeks) lead to a transient 20 to 45 dB threshold shift that 
increased with time and was relatively constant across a certain frequency. The 
cochlear dysfunction could be caused by decreased blood flow to the cochlear 
tissues due to vasoconstriction.
Many studies have been published conceming the influence o f corticosteroids 
on inner ear fluids in the 90s (84-89). Bilateral adrenalectomized rats showed a 
decline in Na+K+ ATPase activity and morphological changes in the stria vascularis, 
spiral ligament and dark cells. Suppletion with aldosterone gave restoration o f  dark 
cell tissue in these rats; suppletion with dexamethasone did not. The highest levels 
o f  GC receptors were observed in the spiral ligament and spiral ganglion cells, 
compared to significantly lower levels o f GC receptors in the stria vascularis. 
Aldosterone binding sites in the inner ear have been demonstrated in ion- 
transporting tissues. The GC receptor protein level in the organ o f Corti was 
significantly decreased by the stress o f  noise exposure with at the same time a rise in 
corticosterone serum levels. In that same field, Lohuis et al. (2000) demonstrated 
that the absence o f adrenal hormones had no effect on most o f the cochlear 
potentials in adrenalectomized guinea pigs (90). The absence o f adrenal hormones 
caused a reduction in volume o f the scala media (imdrops). Evidently, the cochlea 
seems capable o f  compensating for the absence o f  circulating adrenal hormones and 
o f  creating a situation whereby an accurate cochlear conduction is maintained. This 
research group attributes the effects o f the missing adrenals and their hormones to 
aldosterone.
Ferrary et al. measured that the cellular transport systems involved in the 
endolymph secretion are altered by the replacement o f ADH and/ or corticosteroid 
hormones in rats with genetic deprivation o f ADH and in adrenalectomized rats 
(91). Administration o f  aldosterone resulted in (over) production o f endolymph into 
an endolymphatic hydrops in guinea pigs, where the distal part o f  the endolymphatic 
sac was surgically damaged (5).
The data show that stress and its hormones change inner ear fluids 
composition and inner ear function. Stress seems to make the ear less sensitive to 




Effect o f  stress and stress hormones on the healthy human ear
Higher hearing detection thresholds, increased amplitudes o f  auditory evoked 
cortical potentials and higher stapedial reflex thresholds were found in healthy 
individuals taking the synthetic glucocorticosteroid hydrocortisone (92;93). Also, 
ingestion o f hydrocortisone gave significantly reduced latencies o f  auditory 
brainstem waves. It was also seen that after stress induction the contralateral ear 
needed significantly more (louder) noise to generate a stapedial reflex than at 
baseline or control measurements. Moreover, this effect on the stapedial reflex is 
only found in people who had a proven higher level o f plasma cortisol (responders 
versus non-responders).
Furthermore, patients with untreated adrenal insufficiency had lower 
hearing detection and pain thresholds, respectively 11 and 20 dB (94;95). These 
auditory changes normalised after supplementing with exogenous corticosteroids 
(prednisolone).
It is concluded from these findings that GCs impair auditory acuity, 
whereas sensory processing and perceptual integration may be improved.
Stress and stress hormones in patients with Menière’s disease 
The psychological effect o f stress has been discussed in the former chapter. 
Therefore, we only present a summary o f studies conceming stress hormones in 
patients with Menière’s disease. Powers was the first in the metabolic evaluation of 
patients with Menière’s disease (96). He found that 30% had an abnormal glucose 
tolerance test, one third had a lowered adrenocortical reserve (ACTH stimulation 
test) and 27% were hypothyroid. Coletti et al. also performed a comprehensive 
endocrinologie evaluation o f Menière patients, which showed no differences in 
plasma and urine renin-aldosterone, cortisol or ACTH levels compared to healthy 
individuals (97). Elevated plasma concentrations o f  noradrenaline and ADH have 
been reported in patients with inner ear disorders caused by endolymphatic hydrops, 
including Menière’s disease (98). Others have found normal ADH levels in Menière 
patients (99). The plasma aldosterone levels were also found in the normal range in 
patients with Menière’s disease (100). The levels o f  prolactin, growth hormone, 
cortisol and ACTH in Menière patients were not significantly different from patients 
with acoustic neurinoma and with facial spasm (101). Another group also confirmed 
that Menière patients have normal blood prolactin levels (102).
Recent facts on the role of glucocorticosteroids during stress
In recent years the role o f  the glucocorticosteroids (GCs) during stress situations has 
been reassessed. Munck et al. have proposed an altemative functional role for GCs 
in the primary stress responses (103). They suggested that the physiological function 
of stress-induced increases in GC levels is not to protect from the source o f stress 
itself, but from the normal defence reactions. Furthermore, the GCs would 
accomplish this function by tuming o ff those defence reactions, thus preventing 
them from overshooting and threatening homeostasis. In contrast to the traditional
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view that GCs enhance the defence mechanisms, however, is the view that it has 
become increasingly clear that high levels o f  GCs generally suppress them. The use 
o f  high doses o f  GCs in organ transplantation to suppress the immune system is a 
good example o f  this fact. This paradox, which first emerged when GCs were 
discovered as anti-inflammatory agents, remains a major obstacle to a unified 
picture o f  GC function.
Sapolsky et al. considered certain criteria for determining whether a particular 
GC action permits, stimulates or suppresses an ongoing stress response or, as an 
additional category, is preparative for a subsequent stressor (104). The specific 
action o f the GCs depends on the physiological endpoint. The actions are mediated 
through different receptors: the permissive actions through mineralcorticosteroid 
receptors and the suppressive actions through GC receptors.
In 2000 hypocortisolism was given a potential role in the pathophysiology of 
stress-related bodily disorders (105). Hypocortisolism has been found in 
posttraumatic stress disorder patients, healthy individuals living under chronic stress 
and patients with chronic bodily disorders, like fibromyalgia, chronic fatigue 
syndrome, rheumatoid arthritis and asthma. The manifestation o f this neuro- 
endocrine abnormality may be determined by genetic vulnerability, previous stress 
experience, coping and personality styles. These are the same factors that are 
mentioned for stress responses in general. The nature o f  the underlying mechanism 
remains speculative. The paradox o f the simultaneously presence o f hippocampal 
atrophy next to hypocortisolism in chronic stress situations stays a mystery as well.
All put together, there seem to be new considerations in neuro-endocrine 
research in stress-related diseases. Although, the mechanisms explaining these facts 
are not quite clear.
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Multifactor model in Menière’s disease
Previous chapters make it clear that the Menière’s disease is a complex phenomenon 
that cannot be understood in terms o f a single cause and effect relation. Menière’s 
disease comprehends more than vertigo, tinnitus and hearing loss. Moreover, 
regarding Menière’s disease as (the result of) a psychological problem does not give 
the ultimate insight either. For a better understanding it has to be considered as a 
multifactor disease, in which somatic, psychological and environmental aspects have 
to be taken into account.
The model that is presented in Figure 1 is an attempt to illustrate the 
complex interrelations between the factors that are thought to play a role in the 
development and continuation o f the Menière symptoms. The elements described in 
preceding chapters are included in the model.
Firstly, some definitions o f  the mentioned factors in the model will be given 
in short. Stressors are potentially threatening events or situations. Intemal stressors 
arise from the person itself, e.g. fear or vertigo attacks. Extemal stressors are defined 
as daily problems, catastrophic life events or chronic problems. Whether the 
individual perceives or evaluates the stressor as potentially stressful depends on a 
person’s appraisal. Appraisal depends o f  the received characteristics o f  the stimulus, 
psychological structure o f  the individual (primary appraisal) or on the individual’s 
coping style (secondary appraisal). The reaction to the stressor and its appraisal is 
divided in three sub-reactions: psychological, somatic and behavioural responses. 
This is discussed in detail in chapter 3.
As mentioned before, the histopathological substrate for Menière’s disease 
is thought to be the endolymphatic hydrops. In earlier studies, this increase of 
endolymph is related to two processes (5). The first is reduced resorption o f 
endolymph due to anatomical abnormalities in the drainage system o f endolymph. In 
studies is shown that Menière patients have a significant smaller saccus 
endolymphaticus (6) and/or a hypoplastic aquaductus vestibularis (106). The other 
process is related to a temporary increased production o f  endolymph. In animal 
models is shown that stress hormones could increase the endolymph production
(83). Possibly, this may account for the human situation as well. Glucocorticosteroid 
receptors have been found in the human ear (107).
The term “allostatic load” as discussed in the former chapter, may be 
applied to the suggested model. Patients with Menière’s disease are thought to have 
a longstanding increased stress load (allostatic load), because o f their obsessive- 
compulsive and introvert personality structure (39;41;52). Next to this allostatic 
load, the Menière patiënt experiences more fear or stress through the unpredictable 
character o f the disease. This may lead the patiënt into a vicious cycle o f  chronic 
stress (see Figure 1).
A combination o f both factors either causal or conditional, seems to be the 
most eligible theory based upon indicative research and clinical experience. The 
question that arises immediately is why one patiënt recovers after a few attacks, 
while another patiënt develops a chronic disease.
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Figure 1. Multifactor model in Menière’s disease.
HPA axis = Hypothalamus-Pituitary-Adrenal axis; ANS = Autonomie Nervous System
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If  we assume that:
1. certain people are more susceptible to develop Menière’s disease through an 
already abnormal endolymphatic drainage system; and:
2. the presence o f stress hormones adds to the chance o f developing Menière 
symptoms; and
3. Menière patients experience more stress through their disease;
development o f  a vicious cycle o f  stress and Menière symptoms seems obvious 
(Figure 1).
Individuals with M enière’s disease fall into a vicious cycle o f (psychological) 
stress, stress hormones, endolymphatic hydrops, Menière symptoms, (psychological) 
stress etc. Many factors are involved, namely:
The extent to which symptoms lead to an increase in stress mediated through 
personality aspects and/or coping style (appraisal);
The extent to which stress leads to an increase in stress hormone production 
(physiological stress response);
The extent to which an increase in stress hormone production leads to an 
increase in endolymph production (whereby any lesion can play a role as result 
or cause);
The extent to which stress hormones have effects on the hippocampus;
The extent to which stress leads to a certain mental health status (psychological 
stress response).
Aims of this thesis
The main aim o f this thesis is to quantify and qualify certain elements o f this model 
to gain insight why one person develops chronic and more severe complaints after 
getting M enière’s disease and another person does not. The elements in the gray 
boxes were studied in this thesis. In chapter 5 the levels o f cortisol and other stress- 
related hormones in patients with Menière’s disease are compared to healthy 
Controls. The psychological assessment o f patients with Menière’s disease is 
presented in chapter 6 wherein all separate psychological parameters are included. 
The evaluation o f  chronic stress in Menière patients was performed with the 
measurement o f  the hippocampal volume on MRI scans, portrayed in chapter 7. 
Finally, all the elements o f the suggested model are presented in chapter 8 with a 
summary in chapter 9.
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Chapter 5
Introduction
M enière’s disease is a chronic, stressful disease with handicapping symptoms as 
fluctuating hearing loss, tinnitus and vertigo attacks. lts exact pathogenesis is 
complex and remains unresolved. Two-phase endolymphatic hydrops is the most 
commonly used aetiological model. This is based on dysregulation o f the endolymph 
homeostasis, where the endolymph absorption is chronically malfunctioning, 
complicated by an intermittent overproduction o f  endolymph (5). Earlier, it was 
found that the endolymphatic sac was undersized in Menière patients compared with 
healthy Controls (6). Many aetiological explanations have been given for the 
irregular endolymph overproduction.
The psychological aspects in Menière’s disease have frequently been 
studied as cofactors in the pathogenesis o f  or contributors to Menière’s disease 
(108). Because stress seems to influence Menière symptoms in specific patients, it is 
postulated that stress (hormones) affects endolymph homeostasis. Receptors for 
several stress hormones have been located in the human inner ear, including those 
for glucocorticosteroids (107). In animal and human studies, it has been shown that 
stress (hormones) could change inner ear fluid composition and inner ear function 
(83;87;93).
Stress is linked to changes in the hypothalamic-pituitary-adrenocortical 
(HPA) axis. During stress, the hypothalamus releases more corticotrophin-releasing 
hormone and antidiuretic hormone (ADH), which activate the pituitary gland to 
produce more adrenocorticotropic hormone, followed by glucocorticoid (cortisol) 
and mineralcorticoid (aldosterone) secretion. Cortisol is produced in a circadian 
rhythm, and increased levels cortisol are usually found during acute stress and also 
in chronic depressive patients (109). Stressors also activate the sympathetic branch 
o f  the autonomie nervous system, which stimulates the medulla o f  the adrenal gland 
to secrete more catecholamines, especially adrenaline and noradrenaline. Some 
authors have found increased plasma levels o f  noradrenaline, ADH or prolactin in 
Menière patients (54;98;110). In a study by Mateijsen et al., no anomalous plasma 
aldosterone values were measured in patients with Menière’s disease (100).
To our knowledge, the stress hormone cortisol has never been studied in a 
controlled setting in Menière patients. We hypothesise that Menière patients have an 
overproducing neuro-endocrine stress system, which is expressed in higher cortisol 
levels in Menière patients compared with healthy Controls. In this study we 
evaluated the serum, saliva and urine cortisol and the urine noradrenaline and 
adrenaline in a controlled, standardised setting.
Subjects and methoas
Study population
Every week, one patiënt suspected o f having Menière’s disease is admitted at our 
otorhinolaryngology department for 3 consecutive days to confirm the diagnosis 
M enière’s disease and to exclude other audiovestibular diseases by means o f  various
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tests. This includes Standard ear, nose and throat examination, several audiometric 
and vestibular tests; magnetic resonance imaging o f the cerebellopontine angle; 
laboratory tests and evaluation o f symptoms using standardised questionnaires. Two 
weeks before admission, patients discontinued their antivertiginous medication, 
including anxiolytics. Patients were considered having Menière’s disease when they 
had a history o f at least two vertigo attacks lasting longer than 20 minutes, tinnitus 
and sensorineural hearing loss o f at least 60 dB added up from the three worst 
octaves in the same ear, and other pathology had been excluded.
The persons for the control group were voluntarily recruited from 
hospital personnel and through advertisements in a local newspaper. All persons in 
the control group were healthy and were not fmancially compensated for 
participation in this study.
The exclusion criteria for the study are listed in Table 1. The local 
medical ethics committee approved the study and all participants gave written 
informed consent.
Table 1. Exclusion criteria for the study.
Cushing’s disease, hypoglycaemia or diabetes mellitus 
Hypo- or hyperthyroidism 
Liver or renal failure
Medication: corticosteroids (systeraic/local), estrogens, oral contraceptives, androgens, 
amphetamines, barbiturates, benzodiazepines, betahistine, riphampicin, spironolactone, 
aminogluthethimides, danazol, lithium, levodopa, metyrapone, chloordiazepoxide, hydroxyzine, 
mebrobamate, phenothiazines, quinine en phenytoin.
Examination with radioisotopes 
Anorexia nervosa or pregnancy
Methods
The healthy Controls stayed 2 consecutive nights at our department in the same 
condition as the Menière patients. At 8:00 AM, blood was drawn from an 
intravenous catheter, with all the individuals in a supine position and after an 
ovemight fast. The intravenous catheter was placed 30 minutes before obtaining the 
blood to minimise the stress reaction o f  inserting the needle. The venous blood was 
analysed for cortisol and glucose levels.
The first cortisol measurement was obtained without administration o f 
dexamethasone. The night previous to the second cortisol evaluation the participant 
took 1 mg o f dexamethasone at 11:00 PM, conformable to the dexamethasone 
suppression test (DST). The serum cortisol analysis was performed with an in-house 
radioimmunoassay method. The blood glucose level was measured using the APEC 
glucose analyser (APEC Inc., Danvers, MA, U.S.A.).
A 24-hour urine sample was analysed for sodium, potassium, creatinine, 
free cortisol, adrenaline and noradrenaline. The free cortisol was measured by
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radioimmunoassay after extraction with organic solvents and affinity 
chromatography. The catecholamines were evaluated with the high-performance 
liquid chromatography with fluorescence detection. To validate a new cortisol 
evaluation method, we also measured free cortisol in the saliva. The Salivette cotton 
swab (Sarstedt, Nümbrecht, Germany) was placed under the tongue for 2 minutes at 
the same time (8:00 AM) that the venous blood withdrawal took place.
Duration and subjective severity o f symptoms were scored using a 
standardised questionnaire. The duration time o f the Menière symptoms (hearing 
loss, tinnitus and vertigo) was defined as the time between the first appearance of 
the symptoms and the admission date. We defined the total disease time as the 
duration time o f the symptom that occurred first. The duration o f disease in bilateral 
patients is confined to the first affected ear. The subjective severity o f the symptoms 
was assessed as perceived in the last 3 months. Hearing loss could be characterised 
as “unchanged”, “improved”, “worse” or “fluctuating”; tinnitus and vertigo could be 
characterised as “none”, “mild”, “moderate” or “severe”. The hearing loss was 
defined as the average hearing thresholds over five pure-tone audiogram frequencies 
(0.25-4 kHz).
Statistics
Power analysis was based on the difference between the mean serum cortisol levels 
o f  M enière’s disease patients and healthy Controls. If  we hypothesised that the mean 
serum cortisol level in Menière’s disease patients would not be 25% higher than in 
healthy Controls using a power o f  0.80 and a two-sided value o f  p<0.05, 20 
individuals for both groups had to be included. In this power analysis we substituted 
a mean serum cortisol level o f  250 ± 46 nmol/1 (n=8) from a study by Kerstens et al. 
(111). Data are given in mean ± Standard deviation. Statistical analyses were 
performed using the independent sample t-test and the Chi-square test after 
excluding the extremes o f the groups (z < -3 and >3). Values o f p < 0.05 were 
considered to be statistically significant.
Results
Study population
From January 2002 to August 2003, we included 66 patients with audiovestibular 
symptoms in the protocol. We concluded after evaluation o f  all the test results, that 
54 patients had Menière’s disease using the criteria mentioned above. Twelve 
individuals (18%) had other disease (e.g. epilepsy, congenital or hereditary deafness, 
vascular problem, neuronitis vestibularis [n=2] or otosclerosis). Others had vertigo 
without hearing loss (n=2), idiopathic sudden sensorineural hearing loss, or 
cisplatinum toxicity. One had endolymphatic sac dysfunction after ear surgery.
Thirty o f  the 54 patients with Menière’s disease met the cortisol study 
criteria. The exclusion motives were use o f oral contraceptives or estrogens (n=5), 
use o f systemic or local corticosteroids (n=6), use o f anxiolytics or betahistine (n=4), 
hypo- or hyperthyroidism (n=6) and diabetes mellitus (n=3).
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Noteworthy is the fact that 6 o f  the 54 Menière affected patients (11%) had 
preexisting thyroid dysfunction. One o f the patients had undergone endolymphatic 
sac surgery in another hospital. In the included Menière affected group (Menière 
group, n=30) were 21 unilateral (70%) and 9 bilateral (30%) affected individuals. 
The Menière group consisted o f  7 women (23%) and 23 men (77%) with a mean age 
o f 48 and 53 years, respectively. The overall mean age o f  the Menière group was 52 
± 9 years.
Nine o f the 12 patients with other disease (non-Menière group) were also 
included in the study; 5 men (56%) and 4 women (44%). Their mean age was 50 ± 
14 years. Three o f the twelve patients were excluded because o f hypothyroidism 
(n=l), diabetes mellitus (n=l) or use o f  benzodiazepines (n=l).
The original control group consisted o f 20 healthy persons (control group). 
However, 2 men were excluded from analysis because they had taken topical 
corticosteroids. So, the control group contained 18 persons: 8 men (44%) and 10 
women (56%), with a mean age o f 41 and 49 year, respectively. The overall mean 
age o f this group was 45 ±11 years.
The gender and age match between the Menière and the control group was 
not perfect. The Menière group had significantly more male individuals (77% versus 
44%) and was older (mean age, 52 versus 45 years). This difference was significant 
for both variables (p<0.05). The general characteristics o f  both groups are listed in 
Table 2.
Menière group (n=30) Control group (n=18)
Age (years) 52 ± 9 45 ± 11 *
Gender (male/ female) (%) 7 7 /2 3 56 / 44*
Body Mass Index (kg/m2) 25 ±  2.3 24 + 2.6
Mean arterial pressure (mmHg) 104 ± 13 108 ± 10
Pulse (beats/min) 64 ± 9 66 ± 8
Creatinine clearance (ml/min) 107 ± 18 128 ±31 *
Duration slept night before blood sample (min) 417 ±65 378 ±51 *
Duration awake before blood sample (min) 103 ± 59 78 ±48
Other chronic disease (yes/ no) (% ) 3 0 /7 0 6 /9 4 *
Table 2. General characteristics o f Menière and control group. 
* p<0.05, results are presented as mean ± Standard deviation.
None o f the individuals exceeded the ranges o f  the reference values as used 
in our hospital. The reference values are as follows: serum cortisol (200-800 nmol/1), 
DST value (<100 nmol/1), urine free cortisol production (20-270 nmol/24h), urine 




1. Menière versus control group
The results are presented in Table 3. Two o f the 30 blood samples o f  the Menière 
group were not correctly analysed for cortisol measurement. The mean serum 
cortisol levels were 440 ± 127 nmol/1 (median 465; n=28) and 366 ± 90 nmol/1 
(median 348; n=18) for the Menière and control group, respectively. This was a 











200-800 440 ± 127 (28) 450 ± 84 (9) 366 ± 90  (18)*
Saliva cortisol 
(nmol/1)
not available 17.2 ±6.1 (18) 13.3 ±0 .9  (3) 11.6 ± 4 .6  (9)*
Serum cortisol after 
DST (nmol/1)
<100 27 ± 13 (25) 32 ± 14 (6) 21 ± 12(18)
Urine free cortisol 
(nmol/24h)
20-270 102 ±51 (27) 120 ±65 (9) 98 ±58 (18)
Urine noradrenaline 
(|jm/mcrea)
0.1-30 19 ±7.1 (27) 19 ±6.8  (9) 22 ±6.7  (18)
Urine adrenaline 
(|im/mcrea)
0.1-10 3.3 ± 1.5 (28) 3.9 ± 2.2 (9) 5.4 ±2 .0  (18)
Table 3. Cortisol and catecholamine values for the three subgroups.
* p<0.05 between Menière group and healthy Controls. Reference values are presented in minimum to 
maximum and the results for the three subgroups as mean ± Standard deviation. DST= dexamethasone 
suppression test
The saliva cortisol value was significantly higher in the Menière group than 
in the Controls: 17.2 ± 6.1 (n=18) and 11.6 ± 4.6 nmol/1 (n=9), respectively (p<0.05). 
The DST values showed no significant difference: 27 ± 1 3  nmol/1 (Menière group; 
n=25) and 21 ± 12 nmol/1 (control group; n=18). The 24-hour free cortisol 
production in the urine was 102 ± 51 nmol/24h (n=27) and 98 ± 58 nmol/24h 
(n=18), respectively. The adrenaline and noradrenaline levels were comparable for 
the Menière and control group. The Controls had a significantly better creatinine 
clearance than de Menière group, namely 128 ±  31 versus 107 ± 18 ml/min 
(p<0.05).
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Figure 1.Serum cortisol for the 3 subgroups.
2. Menière versus non-Menière group
The mean serum cortisol level was 440 ± 127 nmol/1 in the Menière group (n=28) 
versus 450 ± 84 nmol/1 in the non-Menière group (n=9). There were also no 
significant differences in DST (27 ± 13 and 32 ± 14 nmol/1) and urine free cortisol 
values (102 ± 51 and 120 ± 65 nmol/24h) (Table 3).
3. The Menière group
We also examined the Menière affected group (n=28) for inter-individual variations 
in cortisol levels by dividing this group into high-cortisol (HC) and low-cortisol 
(LC) groups, taking the median serum cortisol value o f 465 nmol/1 as the cutoff 
point. The two groups were matched for age and gender and were equally affected 
unilaterally or bilaterally. The mean DST and urine free cortisol values were not 
significantly different. In one patiënt o f  the LC group two venipunctures failed 
before the blood could actually be taken; the other 27 patients had only one 
venipuncture. Thus, the higher cortisol levels could not be explained by a difference 
in the number o f venipunctures. The mean arterial pressure and pulse o f  the HC and 
LC groups were 102 ± 12 mmHg versus 108 ± 14 mmHg and 63 ± 9 versus 64 ± 10 
beats/min, respectively; this was not significant. The HC group did not have more
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other chronic diseases than the LC group. Individuals in both groups slept the same 
amount o f  time during the night and woke up approximately at the same time, so 
there was no difference in circadian rhythm. The hearing loss was equivalent in both 
groups, 56 ± 23 dB (HC group) and 49 ± 18 dB (LC group).
The total Menière disease time and the duration of tinnitus tended to be 
longer in the HC group (p=0.07, two-tailed). The total Menière disease time was 
13.5 ± 9.9 (n=14) versus 7.1 ± 7.4 (n=14) years in the HC versus LC group. The 
duration time o f tinnitus was 11.9 ± 9.7 (n=14) and 5.8 ± 7.1 years (n=14), 
respectively (p=0.07, two-tailed). The duration of hearing loss and vertigo attacks 
was 10.1 ±  7.6 versus 5.7 ± 6.7 years and 7.6 ± 6.7 versus 5.6 ±  6.0 years, 
respectively. The subjective evaluation o f Menière symptoms as vertigo, tinnitus and 
hearing loss was the same in both groups. These results are presented in Table 4.
Low serum cortisol 
group (n=14)
High serum cortisol 
group (n=14)
Total disease time (years) 7.1 ±7.4 13.5 ± 9 .9 *
Duration hearing loss (years) 5.7 ± 6.7 10.1 ±7.6
Duration tinnitus (years) 5.8 ±7.1 11.9 ± 9 .7  *
Duration vertigo (years) 5.6 + 6.0 7.6 ± 6.7
Severity hearing loss 5 7 /0 /1 4 /2 9 7 1 /0 /1 4 /1 4
(unchanged/better/worse/fluctuating) (%)
Severity tinnitus (none/mild/moderate/severe) (%) 0 / 7 / 5 7 / 3 6 0 / 1 4 / 4 3 / 4 3
Severity vertigo (none/mild/moderate/severe) (%) 3 6 / 2 1 / 1 4 / 2 9 1 5 / 2 3 / 1 5 / 4 6
Vertigo attacks last 3 months (yes/no) (%) 5 0/ 5 0 71 /2 9
Table 4. Disease characteristics o f the high- and low-serum cortisol groups.
* p=0.07, results are presented as mean ± Standard deviation.
Discussion
In this study we confirmed our hypothesis that the serum cortisol and saliva cortisol 
levels were significantly higher in Menière patients compared with Controls. This 
was not caused by higher ectopic cortisol production, confirmed by the normal 
serum cortisol levels after the dexamethasone suppression test and the normal urine 
free cortisol production. Earlier studies by Powers and Colletti did not show any 
cortisol variances in patients with Menière's disease (96;97). In this study, the 
catecholamine production was not elevated in patients with Menière’s disease.
How can these findings be explained and interpreted? It has been shown that 
depressive patients and people having chronic stress have higher levels o f serum 
cortisol (112). This was explained by the allostatic load theory. Allostasis is the 
adaptation to stress, creating a new bodily homeostasis after stress. The term 
“allostatic load” refers to an overload o f the body. It is the price the body has to pay 
for constant allostatic reactions to psychosocial or physical stressful situations. It has 
damaging effects through the continuous secretion o f  catecholamines by the
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autonomie nervous system and glucocorticosteroids by the HPA axis. This allostatic 
load may lead to wear and tear o f organs and tissues, and make individuals more 
susceptible to illness. This could be the explanation o f coronary disease and diabetes 
mellitus, which appear predominantly in people in their 50s. Frequent and chronic 
elevated levels o f glucocorticosteroids could cause atrophy o f the hippocampus. In 
turn, the negative feedback function o f  the hippocampus declines and results in even 
more cortisol secretion in stressful situations. An identical defect in the central 
regulation o f stress hormones could be the case in Menière’s disease. Because the 
DST levels in all participants were normal, it seems that the hippocampus is (not 
yet) depressed in its feedback function. In 1962, Goldman proposed that exhaustion 
o f the adrenocortical reserves because o f continuous stress may play a role in certain 
cases o f M enière’s disease (113).
This study also showed that patients with higher serum cortisol levels tended 
to be longer affected by the Menière symptoms. Patients affected longer by the 
Menière symptoms, are consequently more exposed to physical and psychological 
stress. This suggests that the higher cortisol levels are rather the result than the cause 
of Menière’s disease. The high cortisol levels in non-Menière group seem to confïrm 
this suggestion. It is recommended that other effects o f allostatic load in Menière 
patients (e.g. hippocampal atrophy) are looked for.
Other stress-related factors (e.g. previous stress experience, coping strategies 
and personality characteristics) also affect cortisol levels. This was not analysed in 
this setting, although what we do know is that the subjective experience o f  the 
vertigo, tinnitus and hearing loss did not differ between the LC and HC groups. The 
difference in serum cortisol levels could also be accounted for by the mismatch in 
gender and age. Male gender and older age in the Menière group are both factors for 
a higher cortisol level.
Many clinical studies reported abnormal hormonal levels in Menière 
patients (e.g. noradrenaline, vasopressin (ADH) and prolactin [(54;98;110)). Others 
measured normal levels o f aldosterone and ADH in patients with Menière's disease 
(100;114). Thyroid dysfunction has also been associated with Menière’s disease 
(96; 115). Our results showed that 11% o f the Menière patients had hypothyroidism 
or hyperthyroidism. Because these are subjective, retrospective data, we recommend 
studying thyroid function in a prospective setting.
The question remains o f how stress could generate an exacerbation in 
Menière symptoms in specifïc patients. Maybe the higher cortisol levels affect the 
inner ear and especially the endolymph homeostasis. Several experiments on 
glucocorticosteroids and their receptors in the inner ear have been performed by 
others. They showed that glucocorticosteroid receptors are p resen t‘in inner ear 
tissues within varying levels and that they are responsive to stress (87;89). It seems 
that glucocorticosteroids could directly affect glucocorticosteroid receptors protein 
within the inner ear and not only suppress the systemic release of corticosterone
(84). Furthermore, adrenal corticoids appear to cause changes in auditory thresholds 




The higher cortisol levels in patients with Menière’s disease imply an overproducing 
HPA axis. It is suggested that these higher cortisol levels are rather the result than 
the cause o f  this chronic disease, because patients longer affected by the disease 
seem to have higher cortisol levels. What the exact impact o f these higher cortisol 
levels on the inner ear and endolymph homeostasis could be is yet unknown. It 
remains difficult to measure hormonal levels properly and reproducibly, because so 
many factors have an effect on the stress hormone production.
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Introduction
Menière’s disease is a chronic, stressful disease with disabling symptoms such as 
(fluctuating) hearing loss, tinnitus and spontaneous vertigo attacks. The exact 
pathogenesis remains unknown, but the endolymphatic hydrops is the most 
commonly used pathophysiologic substrate (9). Hydrops is supposed to be caused by 
a congenital or acquired reduction in endolymph absorption and a temporarily 
increased production o f  endolymph (5). lts unpredictable character makes it a 
stressful disease.
Menière’s disease is amongst the conditions in which psychological factors 
are often emphasised. The early literature on psychological considerations in 
Menière’s disease focussed on the psychosomatic causes and somatopsychic effects 
o f  the disease (31 ;35). Neither the psychosomatic or somatopsychic theory does 
seem to be the sole clarification for the development o f  Menière’s disease. Most o f 
the studies are methodologically weak and provide no deflnitive support for the 
claims made (108).
Earlier studies have shown that Menière patients experience more anxiety, 
depression and phobia (50;51;57), while others did not (52). It was also shown that 
Menière patients experience the same level o f  anxiety, depression and somatic 
complaints compared to patients with only vertigo (116). In the field o f personality 
characteristics, previous studies have described Menière patients as obsessive- 
compulsive persons, perfectionists and neurotics, who are supposed to be more 
vulnerable and have more stress exposure (39;41;52). On the other hand, other 
researchers classified the personality of Menière patients in the normal range (54). A 
time-series analysis o f  stress and vertigo expression did not support the role o f  stress 
as a precursor o f  symptoms in Menière’s disease (55). On the contrary, Söderman et 
al. did find that emotional stress increased the risk o f getting a vertigo attack (117).
The former studies evaluated specifïc aspects o f  the psychological process. 
More likely, the disease is characterised by a continuous interaction o f many 
psychological, physical and environmental factors: symptoms o f the disease worsen 
the emotional state, which in turn impairs the (perception of) symptoms. To our 
knowledge, all these factors have never been evaluated simultaneously in one study. 
To outline the psychological process in M enière’s disease, a general model o f stress 
with stressors (physical and psychological disturbances), appraisal (coping and 
personality) and stress responses (psychological, physical and behavioural) is 
presented (Figure 1). All elements have their specifïc place and interrelate in this 
model. Whether the disease or the psychological condition presents first, remains 
unresolved and is probably irrelevant. More important is to know how the emotional 
and physical factors interact and why one patiënt develops more frequent and severe 
problems after getting M enière’s disease than others.
Information about this psychological process and its factors might give us 
better insight into which Menière patients are most at risk and in what way 
psychological support needs to be intensified. In this study, each factor in the model
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Figure 1. Multifactor model o f Menière’s disease.
is qualified and quantified by means o f validated, standardised measures containing 
the appropriate psychometrie properties. Several self-report questionnaires were 
selected to assess daily stressors, coping, personality, physical and mental health and 
quality o f life.
We hypothesized that Menière patients have more daily stressors, cope with 
stressors less adequately, report more psychological symptoms, and have a worse 
quality o f life than healthy reference groups. Moreover, we explore personality traits 
that make Menière patients more vulnerable for stressors.
Patients and methods
Study population
Every week one patiënt suspected o f  Menière’s disease is admitted to our 
otorhinolaryngology department for 3 consecutive days to confirm the diagnosis o f 
Menière’s disease and to exclude other audiovestibular diseases, by means o f  
various tests. The diagnostic work-up includes Standard ear, nose and throat- 
examination, several audiometric and vestibular tests, MRI-scanning o f the 
cerebellopontine angle, laboratory tests and evaluation o f  symptoms using 
standardised questionnaires. Two weeks prior to admission all patients discontinued 
their antivertiginous medication, including anxiolytics. Patients were considered 
having Menière’s disease when they had a history o f  at least two vertigo attacks 
lasting longer than 20 minutes, tinnitus and sensorineural hearing loss o f at least 60 
dB summed from the three worst octaves in the same ear, while other pathology had
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been excluded. Aural fullness was not a requirement o f  the diagnosis, but could be
present as well.
Psychological assessment
During the clinical admission the psychological evaluation o f Menière patients was
performed using the following questionnaires:
1. The Daily Hassles List (APL) quantifïes the frequency and intensity o f 
problems in different circumstances (118). 112 situations are given and have to 
be answered as to whether they had occurred in the past two months. If  a 
positive reaction was given, it also had to be scored as to whether it was “not a 
problem at all (0)”, “not so bad (1)”, “bad (2)” or “very bad (3)”. A higher 
score implies more daily hassles.
2. Coping was assessed with the Coping Inventory for Stressful Situations (CISS) 
(119). 48 strategies o f  coping with stressful situations are mentioned and have 
to be answered from “not at all (1)” to “very strongly (5)”. The CISS has three 
dimensions: task, emotion and avoidance oriented coping. The CISS has been 
translated and validated for the Dutch situation (120).
3. The NEO Five Factor Inventory (NEO-FFI) measures fïve personality domains: 
neuroticism, extraversion, openness to experience, altruism and 
conscientiousness (121). 60 statements have to be answered on a 5-point scale 
ranging from “strongly disagree” to “strongly agree” . Higher scores indicate 
that the specific trait is more pronounced. The NEO-FFI has been translated 
into Dutch and validated for the Dutch cultural situation (122).
4. The Symptoms Checklist (SCL-90) is a multidimensional self-report 
questionnaire measuring physical and psychological complaints on a scale from 
1 to 5 (123;124). It encompasses 90 items containing 8 dimensions: anxiety, 
agoraphobia, depression, somatic complaints, obsessive-compulsive behaviour, 
interpersonal sensitivity (personal inadequacy and inferiority), hostility and 
insomnia. The total score is called psychoneuroticism, which is a measure for 
general level o f psychological and physical dysfunction. Higher scores indicate 
more psychological or physical problems.
5. The General Health Questionnaire (GHQ-12) is designed to screen for minor 
psychiatrie disorders in the general population (125). 12 items are scored as to 
whether the situation was “better (0)”, “the same (0)”, “worse (1)” or “much 
worse (1)” as usual, with higher scores corresponding with a worse mental 
health (126).
6. The 36-item Medical Outcome Short Form Health Survey (SF-36) evaluates 
well-being and functional status (quality o f  life). It contains the following 
dimensions: physical, mental and social fimctioning, role limitations due to 
physical or emotional problems, general health perception, bodily pain and 
vitality. Each dimension has several items with different scales; a lower score 
represents worse functioning in that specific dimension (127).
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The Daily Hassles List is a free translation o f the APL (Alledaagse Problemen 
Lijst), which is a standardised and validated Dutch questionnaire. The other five 
tests are intemationally standardised and validated tests, which have been translated 
into Dutch and validated for the Dutch cultural situation. The normative values o f all 
tests match the Menière cohort for age and are given for gender.
Duration and subjective severity o f  symptoms were scored using a self-report 
questionnaire. The duration time o f Menière symptoms (hearing loss, tinnitus and 
vertigo) was defined as the time between the first appearance o f the symptom and 
the admission date. We defined the total disease time as the duration o f  the first 
presenting symptom. The duration o f disease in those with bilateral disease was 
confined to the first affected ear. The subjective severity o f  the symptoms was 
assessed as perceived in the last 3 months. Hearing loss could be characterised as 
“unchanged”, “ improved”, “worse” or “fluctuating” ; tinnitus, aural fullness and 
vertigo as “none”, “mild”, “moderate” or “severe”. The patients also had to score 
whether they had experienced vertigo attacks lasting more than 20 minutes in the 
past three months.
Furthermore, the symptoms o f hearing loss, tinnitus, aural pressure and vertigo 
had to be rated by the patients as “none”, “mild”, “moderate” and “severe” (1-4) as 
experienced in the past week. The total severity symptom score is a summation o f 
these four separate scores (variance 4-16). The median total severity symptom score 
for the 110 patients was 10 and served as the cut-off point for creating the low 
(LSG) and high severity symptom group (HSG).
The presence o f  another chronic disease besides M enière’s disease, alcohol and 
nicotine usage, and education level had to be noted as well. The hearing loss was 
defined as the extended Fletcher index over 5 pure-tone audiogram frequencies (0.25 
- 4 kHz). Informed consent was obtained from all participants and the study was 
approved by the medical ethics committee o f  our hospital.
Statistics
Data are given in mean ± Standard deviation (SD). Statistical analyses were 
performed using the Student’s t-test, Chi-square and Mann-Whitney-test. Two-tailed 
p-values were used for all tests. Pearson product-moment correlation coefficients 
were used to examine relationships between variables. If appropriate, we made 
Bonferroni corrections for multiple comparisons. For each test we set the alpha level 
at 0.05 divided by the number o f comparisons. For instance, for 10 comparisons p = 





From January 2002 to January 2005 132 consecutive patients with audiovestibular 
symptoms were admitted for clinical assessment. We diagnosed 111 patients with 
M enière’s disease and 21 individuals (16%) with other pathology after evaluation o f 
all the test results. This other pathology included acoustic neurinoma, otosclerosis, 
neuritis vestibularis, ototoxicity, benign paroxysmal positional dysfunction, 
migraine, hereditary hearing loss and partial epilepsy. Those patients with other 
audiovestibular diseases were considered as a control group. One Menière patiënt 
could not participate in the psychological assessment because o f language problems. 
O f the 110 Menière patients were 81 patients unilaterally (74%) and 29 bilaterally 
(26%) affected.
The study population consisted o f  67 male (61%) and 43 female (39%) 
patients with a mean age o f  52 ± 12.1 and 52 ± 10.3 years, respectively. The male 
Menière patients had a total disease time o f 8.3 ± 7.0 years compared to the female 
group 8.0 ± 6.0 years. In this matching two outliers o f  the male group were 
excluded. They had a disease time o f 36 and 56 years due to other ear problems. 
When they were included, the male total disease time was 9.4 ± 9.6 years. The total 
disease time was not significantly different for gender with or without the outliers.
A similar proportion o f men (31/67; 46%) and women (23/43; 54%) had 
another chronic disease. The extended Fletcher index for the male and female group 
was respectively 53 ± 20.3 dB and 49 ± 19.9 dB. Male and female patients rated 
their hearing loss, tinnitus and vertigo o f  the past three months and the last week 
comparable and had a similar frequency o f  vertigo attacks lasting longer than 20 
minutes in the past three months. The female patients had a significantly lower 
alcohol intake (p<0.001, Chi square test). The education level was equal for both 
genders.
Psychometrie results
Published normative data for all the questionnaires are derived from their respective 
manuals or papers (see methods section) and are given for gender. The results o f the 
six questionnaires are presented in Table 1 and 2. Some questionnaire test results 
had too many missing values and were therefore not used in the analysis. The main 
results are outlined below.
The Menière patients, male and female, experienced more daily hassles 
compared to the normative values (Table 1). Also, they were less task oriented in 
their way o f coping with stressful situations. Moreover, the male patients were also 
less emotion and avoidant oriented in their coping (Table 1). The personality test 
(NEO-FFI) showed that the Menière patients had no abnormal personality traits 
compared to the reference values (Table 1).
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Menière patients Reference values
Male (n) Female (n) Male (n) Female (n)
APL Frequencya 28.2 ± 13.3 (63)* 22.8 ± 15.9 (39)* 18.5 ± 13.0 (504) 15.8 ±12.4 (602)
APL Intensity' 1.17 ±0.45 1.27 ±0.64 1.23 ±0.51 1.24 ±0.32
CISS Task orientedb 53.5 ± 11.5(65)* 46.3 ±12.4 (41)* 59.8 ± 8.4 (374) 60.9 ± 8.9 (309)
CISS Emotion orientedb 33.5 ± 9.2* 38.0 ± 13.2 36.7 ± 10.1 40.2 ± 10.7
CISS Avoidant oriented b 36.8 + 10.5* 44.2 ± 11.3 46.6 ± 9.8 48.2 ±9.7
NEO-FFI Neuroticism' 29.6 ± 8.6 (67) 33.8 ± 7.8 (42) 29.6 ±7.8 (958) 32.2 ±8.2 (1390)
NEO-FFI Extraversionc 37.4 ± 6.9 37.4 ± 6.6 39.8 ± 6.5 40.3 ± 6.6
NEO-FFI Opennessc 36.3 ± 7.4 36.5 ± 5.9 35.4 ± 6.6 36.3 ±6.3
NEO-FFI Altruism' 43.8 ± 5.0 47.2 ±5.1 42.5 ±5.1 45.1 ±5.0
NEO-FFI 45.3 ± 6.0 45.9 ±5.7 45.3 ± 5.7 45.3 ±5.6
Conscientiousnessc
Table 1. APL, CISS and NEO-FFI results o f Menière patients and reference values.
Values in mean ± Standard deviation; * p<0.05, t-test, Bonferroni correction applied; reference values 
froma Vingerhoets & Van Tilburg 1994; b De Ridder et al. 2004;c Hoekstra et al. 1996.
Menière patients 
Male (n) Female (n)
Reference values 
Male (n) Female (n)
SCL-90
Psychoneuroticsm *
133.3 ±34.4 (67)* 147.8 ± 38.5 (43)* 117.2 ±27.3 (432) 128.9 ± 36.4 (577)
GHQ-12b 2.24 ± 2.94 (66) 3.29 ±3.39 (41) < 1 <1
SF-36 Physicalc 79.3 ± 20.0 (67) 73.0 ±20.7 (43) 85.4 ±21.0 (976) 80.4 + 24.2 (766)
SF-36 Role-physical' 59.9 ± 40.9* 43.7 ±43.7* 78.7 ±34.1 73.8 ± 38.5
SF-36 Bodily painc 79.1 ±23.2 71.0 ±24.5 77.3 ±22.7 71.9± 23.8
SF-36 General health0 59.3 ± 17.9* 58.7 ±20.1* 71.6 ±20.6 69.9 ± 20.6
SF-36 Vitalityc 60.4 ±20.1* 55.1 ±21.6 71.9 ± 18.3 64.3 ± 19.7
SF-36 Social fiinctioning0 70.8 ±24.1* 66.8 ±31.0* 86.0 ±21.1 82.0 ± 23.5
SF-36 Role-emotionalc 79.8 ± 34.6 74.4 ±39.1 85.5 ±29.9 78.5 ± 35.7
SF-36 Emotional healthc 73.4 ±17.2 70.7 ± 18.7 79.3 ± 16.4 73.7 ± 18.2 
1 i
Table 2. SCL-90, GHQ-12 and SF-36 results o f Menière patients and reference values.
Values in mean ± Standard deviation, * p<0.05, t-test, Bonferroni correction applied; reference values 
from a Arindell & Ettema 1986;b Koeter & Ormel 1989;c Aaronson et al. 1998.
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The SCL-90 results illustrated that the Menière patients experienced more 
psychological and physical problems (Table 2). A GHQ-12 score o f  more than one 
indicates psychopathology (Table 2). In that case, 63% o f the Menière patients 
showed psychopathology; 71% o f the female and 58% o f the male Menière patients. 
According to the SF-36 scores (quality o f  life), the Menière patients had more 
limitations due to their restricted physical functioning. They had a worse general 
health perception and poorer social functioning with less vitality (Table 2). The 
SF-36 results are also shown in a bar graph to illustrate the differences from the 
control group and patients with migraine and rheumatoid arthritis (Figure 2). The 
mean values from the last two groups are from studies by Aaronson et al. and Kvien 
et al. and the exact values are presented in Table 3.
For further comparison the study population was divided into two 
subgroups; one with a short duration o f  disease (< 3 years, n=33) and one with a 
long duration o f disease (> 3 years, n=77). The patients who were longer affected by 
the disease (> 3 years) had significantly more daily stressors (APL), worse physical 
and social functioning, and more bodily pain (SF-36). They were also less vital 
(SF-36). Both groups did not differ in their psychometrie results for coping 
strategies (CISS), personality traits (NEO-FFI), mental health (GHQ-12) and 
psychoneuroticism (SCL-90).
Menière patients Control group Migraine patients Rheumatoid
(n=l 10) (n=20) (n=423)a arthritis (n=1030)b
Physical 76.9 ± 20.4 76.3 ± 27.0 82.4 ±21.3* 47.3*
Role-physical 54.1 +42.4 62.5 ± 46.2 62.2 ± 40.8 27.0*
Bodily pain 75.9 ± 23.9 71.3 ±23.3 64.9 ±22.4* 41.0*
General health 59.1 ± 18.7 56.8 ± 15.3 67.5 ± 20.5* 42.0*
Vitality 58.3 ± 20.8 55.3 ±21.6 61.1 ± 18.6 39.4*
Social functioning 69.2 ± 26.9 70.6 ± 32.0 76.2 ± 20.9 63.7
Role-emotional 77.7 ±36.3 72.0 ±42.0 74.5 ± 37.8 52.0*
Emotional health 72.4 ± 17.8 66.6 ± 20.0 72.0 ± 18.7 68.1
Table 3. SF-36 results o f Menière, control, migraine and rheumatoid arthritis patients.
Values in mean ± Standard deviation, * p<0.05, t-test between Menière patients vs. control and Menière 
patients vs. migraine patients and Menière patients vs. rheumatoid arthritis patients, Bonferroni correction 
applied; * Aaronson et al. 1998; b Kvien et al. 1998.
The psychometrie results o f  the 110 Menière patients and the results o f  the 
patients with other audiovestibular diseases (control group, n=21) were compared. 
This showed no significant difference in any o f the psychological test results (Mann- 
Whitney-test). The statistical comparison between these two groups is underpowered 
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Figure 2. SF-36 results for Menière patients, control group, migraineurs, patients with rheumatoid 
arthritis and reference values (see also Table 3).
Both groups o f patients with low and high severity symptom scores (LSG 
and HSG) were equally affected by the presence o f other chronic diseases and had 
the same total disease time. The HSG experienced significantly more psychological 
and physical problems (SCL-90) and a worse quality o f  life (SF-36) (Table 4). No 
differences in daily stressors, coping or personality were found between the patients 
with mild and severe symptoms.
This study also showed some correlations between different psychological 
parameters, using Pearson product-moment correlation coefficients. Emotion 
oriented coping strategy use was positively correlated with neuroticism (r=0.68) and 
negatively correlated with conscientiousness (r=-0.21). Also, emotion focused 
coping was correlated with psychoneuroticism (r=0.49, SCL-90), general health 
(r=-0.30, SF-36) and mental health (r=0.35, GHQ-12). Task oriented coping was 
positively correlated with extraversion (r=0.32). The total severity symptom score 
was significantly correlated to neuroticism (r=0.27, NEO-FFI), psychoneuroticism




LSG (n) HSG (n)
APL Frequency 27.2 ±14.3 (52) 24.9 ± 14.8(50)
APL Intensity 1.15 ±0.50 1.27 ±0.56
CISS Task oriented 52.3 ± 11.4 (54) 49.1 ± 13.2 (52)
CISS Emotion oriented 34.3 ± 10.5 36.2 ± 11.7
CISS Avoidant oriented 38.7 ± 10.8 40.6 ± 11.9
NEO-FFI Neuroticism 29.5 ± 8 .7  (55) 32.9 ±8.1 (53)
NEO-FFI Extraversion 37.8 ± 7.3 37.0 ±6.2
NEO-FFI Openness 36.4 ± 6.5 36.3 ± 7.3
NEO-FFI Altruism 44.6 ± 5.3 45.6 ±5.3
NEO-FFI Conscientiousness 46.3 ± 5.8 44.7 ± 6.0
SCL-90 Psychoneuroticsm 129.0 ±31.4 (55) 149.4 ±39.1 (54)*
GHQ-12 2.11 ±2.85 (54) 3.19 ±3.40 (52)
SF-36 Physical 82.5 ± 17.7(55) 71.2 ±21.7 (54)*
SF-36 Role-physical 69.6 ± 39.0 37.7 ±40.3*
SF-36 Bodily pain 82.1 ±20.6 69.2 ± 25.5*
SF-36 General health 64.4 ± 18.2 52.9 ± 16.9*
SF-36 Vitality 65.5 ±  17.6 50.3 ± 20.6*
SF-36 Social functioning 79.2 ±21.3 58.8 ±28.4*
SF-36 Role-emotional 81.2 +  32.6 74.1 ± 39.8
SF-36 Emotional health 77.8 ± 13.3 66.5 ± 20.0*
Table 4. Psychological results for the low (LSG) and high severity symptom group (HSG) of Menière 
patients.Values in mean ± Standard deviation, * p<0.05, t-test, Bonferroni correction applied.
Discussion
This study showed that Menière patients had a deviant psychological profile 
compared to published normed values. Menière patients experienced more daily 
stressors and used certain coping strategies less often. There was also more 
psychopathology and a worse quality o f  life in Menière patients. No abnormalities in 
personality were found.
To our knowledge no analysis has been carried out which evaluated all 
these separate factors in one study. The psychological test results seem comparable 
to other studies. The psychopathology (e.g. anxiety and depression) in Menière 
patients was also found by other researchers (50;51 ;57). The obsessive-compulsive 
and neurotic personality found by others, could not be confirmed in our study 
(39;52). Sawade et al. also classified the personality structure in the normal range 




It has also been shown that Menière patients experience a bad quality o f life 
and vertigo seems to be the most influencing factor in the major implications o f this 
disease on their daily lives (58;59; 128). A strong sense o f  coherence (ability to cope 
with stressful situations) appears to be an important predictor o f  Menière patients’ 
perception o f symptoms and quality o f life according to Söderman et al. (61). They 
suggested that the quality o f  life or perception o f  the disease is also a result o f the 
patient’s ability to cope with difficult life situations. This is also seen in our study 
with the positive correlation between emotion oriented coping and 
psychoneuroticism (SCL-90) and a negative correlation with general health (SF-36). 
However, coping strategies and the frequency o f daily stressors were the same in the 
low and high severity symptom group, while the quality o f life was significantly 
worse in patients with more severe symptoms. This suggests that the severity o f the 
symptoms in Menière’s disease has more effect on the quality o f  life than coping or 
daily stressors. Kinney et al. also evaluated the quality o f  life o f  Menière patients 
with the SF-36 questionnaire (60). In contrast to our findings, they found that 
patients with M enière’s disease have a greater emotional than physical disability. It 
is difficult to compare both studies since Kinney included patients with surgical 
treatment and only unilaterally affected patients.
How do these results fit in our theoretical model? Firstly, it needs to be 
mentioned that causal relations are not justified because o f  the cross-sectional 
character o f this study. It is not defendable to consider this model as causative. 
Therefore, the psychological aspects are presented as a descriptive study.
It seems obvious that patients with this unpredictable and disabling disease 
have more stressors. Nevertheless, patients with more severe symptoms did not 
experience more stressors than the patients with mild symptoms according to the 
APL scores. This could be explained by the fact that the general stressors which are 
mentioned in the questionnaire are not disease-related. The presence o f more daily 
stressors next to disease-related stressors implies some overload o f  the stress system.
Menière patients recruited fewer task oriented strategies for coping with 
stressful situations. This implies that they coped with stressors less 
adequately. There is much debate on which coping strategies are most adequate in 
which situations; task oriented coping is generally more effective. People’s ability to 
modify their coping according to the situational demands is sometimes referred to as 
coping flexibility, which involves the systematic use o f a variety o f  strategies across 
different situations rather than the more rigid application o f a few coping strategies 
(129). So, less use o f  coping strategies overall may be a sign for inadequate 
coping. Our results suggest that coping was a stable factor with prolonging disease 
time, but due to the cross-sectional design o f  this study we can not draw conclusions 
in this respect.
The fact that the psychological outcomes did not differ between Menière 
patients and patients with other audiovestibular disease, emphasises the notion that 
the psychopathology seems to be the result o f  having a chronic disease. The 
psychological profile o f  Menière patients seems more or less comparable to those of 
patients with other chronic diseases. Patients with migraine and asthma also show
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more depression and anxiety disorders than normals (130; 131). Data show that 
migraineurs and patients with chronic fatigue syndrome are more neurotic, and that 
the latter group also has lower self-esteem and are more introvert (131; 132). It is 
suggested that the neurosis is related to anxiety and depression; and it is a reaction to 
the chronic illness. Asthmatics do not seem to have specific personality traits (133). 
As shown in Figure 2 and Table 3, the quality o f  life in Menière patients appears to 
be more equivalent to migraine patients than rheumatoid arthritis patients (127; 134). 
The Menière patients had worse physical functioning, general health and social 
functioning, but less bodily pain than migraineurs. This could be explained by the 
continuously present tinnitus and hearing loss in Menière patients, which could give 
more physical problems and no real painful moments as a result o f  the disease. 
Rheumatoid arthritis has more impact on all the eight dimensions o f the quality of 
life.
The knowledge o f the specific psychological problems and the quality of 
life in patients with Menière’s disease, gives us insight as to where, when and how 
we should give psychological support. It was seen that Menière patients with longer 
disease duration had more daily stressors and worse quality o f life in certain 
dimensions. Statements on changes in the psychological profile occurring over time 
can not be made due the cross-sectional character o f  the study. Furthermore, patients 
with more severe subjective complaints from their disease had more 
psychopathology, were more emotionally unstable and had a worse quality o f life. 
Patients with severe symptomatology did not differ in personality or coping from the 
ones with mild symptomatology. Therefore, the question why some Menière patients 
develop more intense symptoms than others, could not be answered from this study.
Conclusion and recommendations
Menière patients have a deviant psychological profile compared to published 
normed values, but comparable to patients with other chronic diseases. Many 
psychological factors and the symptoms o f the disease seem to interact. To interfere 
in this psychological process, we need to break in by reducing the severity o f 
symptoms with hearing aids and medication. Next to that, the psychological support 
needs to be intensified where needed. The coping and psychopathology (e.g. anxiety 
and depression) should be approached by a psychologist or a psychiatrist. The 
impact o f  the disease on the daily functioning (mental, physical and social) should 
also be a point o f  attention. When Menière patients are helped with these issues, 
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Introduction
Menière’s disease is a chronic inner ear disease with disabling symptoms: 
spontaneous vertigo attacks, hearing loss, tinnitus and aural fullness. Endolymphatic 
hydrops is the most commonly used pathophysiologic model, but the exact 
pathogenesis remains unclear (8). It is a common observation in clinical practice and 
seen from earlier studies that Menière patients experience more stressful events, 
have more psychopathology and a poor general health perception (135). Stress could 
play a role in the development or precipitation o f the symptoms (117).
In general, stress leads to higher levels o f  stress hormones, e.g. 
glucocorticosteroids (cortisol) and catecholamines, through activation o f  the 
hypothalamic-pituitary-adrenal axis (HPA axis) and the autonomie nervous system 
respectively. Animal studies have shown that stress and chronically elevated cortisol 
levels generate selective hippocampal atrophy (136). Human hippocampal atrophy 
with HPA axis dysregulation and memory impairment has been found in affective 
disorders (73;74), Cushing’s disease (75), human aging (77), Alzheimer’s disease 
(78) and in posttraumatic stress disorder (79). Some researchers did not find 
differences between hippocampal volumes o f  depressed patients and control subjects 
(109; 137). All these studies used magnetic resonance imaging (MRI) for 
hippocampal volume measurement. It is thought that the individuals with 
hippocampal atrophy are subjected to enduring stress and high levels o f  cortisol. The 
wear and tear o f  the body due to chronic stress, including the hippocampus, is called 
allostatic load (68).
The hippocampus is located in both temporal lobes and involved in 
memory, leaming and emotion. It also plays a role in the negative feedback o f  the 
HPA axis (71). Therefore, hippocampal atrophy may not only be a result o f  higher 
glucocorticosteroid levels, but may also lead to increased levels o f  circulating 
glucocorticosteroids.
It is hypothesised that M enière’s disease with its unpredictable and 
handicapping nature leads to a vicious cycle o f chronic stress, allostatic load and 
consequently hippocampal atrophy. The aim o f this study was to evaluate the 
hippocampal volumes in patients with M enière’s disease. Two blinded raters 
measured the hippocampal volumes o f 10 patients with Menière’s disease and 10 
healthy Controls using MRI scans. Saliva cortisol and the frequency o f  daily 




Patients were considered having Menière’s disease when they had a history of at 
least two vertigo attacks lasting longer than 20 minutes, tinnitus and sensorineural 
hearing loss o f at least 60 dB added up from the three worst octaves in the same ear, 
and other pathology had been excluded. The diagnostic work-up included Standard 
ear, nose and throat examination, several audiometric and vestibular tests; magnetic 
resonance imaging (MRI) o f the cerebellopontine angle; laboratory tests and 
evaluation of symptoms using standardised questionnaires. Two weeks before 
scanning, patients discontinued their antivertiginous medication, including 
anxiolytics. We defined the total disease time as the duration time o f the first 
presenting symptom until the day o f MRI scanning. The total disease time in 
patients with bilateral complaints was calculated from the time the first ear was 
affected. The presence or absence o f another chronic disease besides Menière’s 
disease was also noted. The hearing loss was defined as the extended Fletcher Index 
over five pure-tone audiogram frequencies (0.25-4 kHz). MRI scanning o f the 
cerebellopontine angle was part of the diagnostic work-up to exclude intratemporal 
or retrocochlear pathology. During the same session, we scanned the total brain 
including the hippocampal region using a 3D-scan.
The control group included healthy volunteers without any signs o f 
Menière’s disease. In this group only a 3D-scan o f the whole brain was made. All 
participants o f this study had no neurological conditions, history o f  myocardial 
infarction or head trauma, hypertension, diabetes, Cushing’s disease, alcohol or 
drugs abuse and did not use corticosteroids. We started with a pilot study with 10 
persons in each group. The local medical ethics committee approved the study and 
all participants gave written informed consent.
Methods
MRI parameters, processing o f the images and segmentation
Tr weighted M R images were obtained on a 1.0 Tesla scanner (Vision, Siemens, 
Erlangen, Germany). The 3D-volume was acquired using a magnetisation prepared 
rapid gradiënt echo (MPRAGE) technique (TR 30 msec, TE 5 msec and flip angle 
30°). The pixel size was 0.977 x 0.977 mm with a slice thickness o f 1.2 mm, matrix 
size of 256 x 256 and FOV o f 256.
The segmentation of the right and left hippocampus was done with a manual 
tracing method using a mouse-driven cursor and light pen system on a display 
console. The tracing was performed on a workstation using Imod software 
(University of Colorado, Boulder, Colorado, U.S.A.), which is originally designed 
for 3D-reconstructions o f electron microscopy cells. The greyscale threshold was 
judged visually. The volumes were digitally calculated using the given voxel size. 





Anatomical borders o f the hippocampus
The hippocampus is a sea-horse-like structure in the medial temporal lobe o f both 
hemispheres. The anatomical borders o f  the hippocampus for segmenting were 
chosen according to the protocol o f  Watson et al. (138). The anterior border o f  the 
hippocampus was marked in the coronal slice in which the mamillary bodies were 
seen, which served as delineation between amygdala and hippocampus. The 
posterior demarcation was defined at the slice where the fomix was visible as a 
continuous tract. The borders o f  the hippocampus were defined as grey matter, 
whereby the superior border included the inferior hom o f the lateral ventricle. The 
collateral white matter in the parahippocampal gyrus served as the inferior border. 
The subiculum and the uncal sulcus were included in the segmentation (Figure 1). 
The anterior and posterior borders o f the hippocampus were defined by the first 
rater.
Figure 1. Segmentation o f  the hippocampus on MRI scan with 3 times enlargement.
Correction for head size
The total brain and intracranial surface was segmented on those slices where the 
hippocampus was present on. The brain surface was defined as all the brain tissue o f 
both hemispheres (gray and white matter) excluding the cerebellum and brainstem. 
Intracranial volume was defined as all the contents directly under the skull with the 
inferior border o f  the both hemispheres as the caudal margin. Both volumes were 
calculated using traced surface, voxel size and length o f  the hippocampus. This was 
different for the right and left hippocampus. Knowledge o f these volumes was 
obligatory to correct for variation in brain size (139). Herewith, the relative 
hippocampal volume was determined as a ratio: hippocampal volume to partial brain 
volume and hippocampal volume to partial intracranial volume.
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Saliva cortisol measurement was performed at 8:00 AM with a Salivette cotton swab 
(Sarstedt, Nümbrecht, Germany). The saliva was evaluated for cortisol with an in­
house radioimmune assay method. Normal values at 8:00 AM are 16 ± 1.7 nmol/1 
for men with a range o f 6.4 to 32 nmol/1, and 9.8 ± 3.1 nmol/1 for women with a 
range o f  4.8 to 18 nmol/1 (70).
All participants were screened for daily stressors using “Daily Hassles List”, 
which quantifies the frequency and intensity o f  problems in different circumstances 
(118). 112 situations are given and have to be answered, whether they had occurred 
in the past two months. If  a positive reaction is given, it also had to be scored 
whether it was “not a problem at all (0)”, “not so bad (1)”, “bad (2)” or “very bad 
(3)”. A higher score implies more daily hassles. “Daily Hassles List” is a free 
translation o f “Alledaagse Problemen Lijst”, which is a standardised and validated 
Dutch questionnaire.
Statistics
Data are presented as means ± Standard deviations. Chi-square, Mann-Whitney and 
Wilcoxon signed ranks test were used to evaluate differences between groups. 
Significance is reached at a level o f  p<0.05. The intra- and inter-rater reliability will 
be presented as intraclass correlation coefficients (140). The intra-rater reliability 
could be calculated by segmenting 10 hippocampi twice with a certain time interval 
by the two raters. The one-way ANOVA is used in this calculation. Intraclass 
correlation coefficients (ICC) above 0.7 are considered reliable.
Results
Study population
Ten Menière patients and 10 healthy control participants were matched for age, 
gender, height, weight and the presence o f other chronic diseases. Six Menière 
patients were right and 3 left handed, one patiënt was ambidextrous. All participants 
o f the control group were right handed. The saliva cortisol levels and presence o f 
daily stressors were similar in both groups (Table 1).
In the Menière group 7 patients were unilaterally and 3 were bilaterally 
affected. The mean total disease time was 9.9 years with a minimum o f 2.0 and 
maximum o f 21 years. Mean hearing loss was 56.4 ± 13.1 dB. Three o f  the 10 
Menière patients had another chronic disease: two patients had hyperthyroidism and 
one had persistent complaints following lumbar disc hemiation.
Cortisol and stressors analvsis
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Menière group (n=10) Control group (n=10)
Age (years) 50.6 ±11.5 48.4 ± 8.9
Gender (male/female) 6/4 5/5
Height (cm) 178.3 ±7.4 174.6 ±8 .6
Weight (kg) 79.8 ± 9.2 75.5 ± 13.2
Handedness (right/left/ambidextrous) 6/3/1 10/0/0*
Saliva cortisol (nmol/1) 16.4 ±5.7 11.7 ±4.4
APL score total score 39.3 ±25.8 24.6 ± 18.3
Other chronic disease (yes/no) 3/7 0/10
Table 1. General characteristics o f Menière and control group.
Results presented in mean ± Standard deviation; * p<0.05 (Chi square test).
Hippocampal segmentation results
The results are presented as mean ± Standard deviation in Table 2. For the Menière 
and control group the first rater measured mean hippocampal volumes o f 2.80 ± 0.36 
cm3 vs. 3.15 ± 0.52 cm3 (right) and 2.49 ± 0.32 cm3 vs. 3.06 ± 0.46 cm3 (left), 
respectively. The second rater measured 3.44 ± 0.35 cm3 vs. 3.60 ± 0.52 cm3 (right) 
and 3.00 ± 0.40 cm3 vs. 3.42 ± 0.45 cm3 (left), respectively. The raw data o f both 
raters are presented in Figure 2.
The absolute volume o f the left hippocampus was significantly smaller in 
Menière patients compared to the control group for both raters (p<0.05). The right 
hippocampal volume was similar in the two groups. Furthermore, the length o f  the 
right and left hippocampus was 28.6 ± 2.5 and 27.6 ± 3.1 mm in the Menière group 
and 28.8 ± 2.0 and 28.6 ± 2.7 mm in the control group, respectively (Table 2).
Menière group (n=10) Control group (n=10)
Right hippocampal volume rater 1 (HR1) (cm3) 2.80 ± 0.36 3.15 ±0.52
Left hippocampal volume rater 1 (HL1) (cm3) 2.49 ± 0.32 3.06 ± 0.46*
Right hippocampal volume rater 2 (HR2) (cm3) 3.44 ±0.35 3.60 ±0.52
Left hippocampal volume rater 2 (HL2) (cm3) 3.00 ± 0.40 3.42 ± 0.45*
Right hippocampal length (mm) 28.6 ±2.5 28.8 ±2.0
Left hippocampal length (mm) 27.6 ±3.1 28.6 ±2.7
Table 2. Hippocampal volume and length results.





Figure 2. Absolute right and left hippocampal volume (mm3) for both raters in all participants.
Participant number 1-10 Menière patients and 11-20 Controls.
The hippocampal volumes were corrected for variation in head size with the 
partial brain volume and partial intracranial volume. No significant differences in 
relative hippocampal volumes were observed between Menière patients and the 
control group (Table 3).
The Menière group could be divided into two subgroups o f each five 
patients, a short-term disease and a long-term disease group. The mean total' disease 
time for the respective groups was 2.5 ± 0.6 and 17.2 ± 2.4 years. Both small groups 
did not differ in absolute and relative hippocampal volume, saliva cortisol level or 
frequency of daily stressors. Furthermore, all right handed male Menière patients 
(n=5) were compared to right handed male Controls (n=5). No differences were
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Menière group (n=10) Control group (n=10)
Partial brain volume right (BR) (cm3) 259 ± 2 6 277 ± 33
Partial brain volume left (BL) (cm3) 252 ±31 274 ±35
Partial intracranial volume right (CR) (cm3) 386 ± 3 6 395 ± 53
Partial intracranial volume left (CL) (cm3) 378 ± 49 393 ± 58
Ratio rater 1 (HR1/BR) x 104 109 ± 16 115 ± 20
Ratio rater 1 (H Ll/B L)x 104 100 ± 15 112 ± 16
Ratio rater 2 (HR2/BR) x 104 134 ± 1 6 131 ± 20
Ratio rater 2 (HL2/BL) x 104 120 ± 15 126 ± 17
Ratio rater 1 (HR1/CR) x 104 73 ± 11 81 ± 16
Ratio rater 1 (HL1/CL) x 104 67±  11 79 ± 13
Ratio rater 2 (HR2/CR) x 104 90 ± 11 92 ± 15
Ratio rater 2 (HL2/CL) x 104 80 ± 11 88 ±15
Table 3. Hippocampal volume results in relation to brain and intracranial volume. 
Results presented in mean ± Standard deviation; Mann Whitney test.
Comparison o f  right and left hippocampal volumes o f  all participants 
showed that the left hippocampal volume was significantly smaller for both raters 
with and without correction for head size (n=20, p<0.05)
Correlations
The inter-rater correlation coëfficiënt was 0.47 and the intra-rater correlation 
coëfficiënt was 0.84 for rater 1 and 0.81 for rater 2. The partial brain volume and 
partial intracranial volume were significantly positively correlated (r=0.788 at the 
0.001 level, Pearson product-moment correlation coëfficiënt).
Discussion
Hippocampal atrophy was not found in patients with Menière’s disease compared to 
healthy Controls. Correction for head size with partial brain and intracranial volume 
dissolved the smaller absolute left hippocampal volume in Menière patients. 
Furthermore, the Menière patients who were longer affected by the disease had 
similar hippocampal volumes as the patients with shorter disease time.
In general, results o f  hippocampal volumetry studies vary largely due to 
different data acquisition, software and definition o f  the anatomical borders (141). 
This makes it almost impossible to compare results o f  separate studies. Each study 
has its own normative data for hippocampal volume, which ranges from 2.8 to 5.3
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cm3 for the right and 2.4 to 4.9 cm3 for the left hippocampus (138;142). The right 
hippocampus is generally larger than the left, which was confirmed in this study.
There were several study limitations. Firstly, the difference between 
hippocampal volumes o f the two raters was significant. This difference occurred 
because the second rater drew the contours on the MRI slices systematically 0.5 
pixel more to the outside than rater 1 (Figure 2). Nevertheless, the differences 
between the Menière and control group, and right vs. left hippocampal volumes, 
were comparable for both raters. In addition, the sample size was limited. Therefore, 
the results need to be interpreted cautiously and it is advised to study larger groups.
The hypothesis o f hippocampal atrophy and HPA axis dysregulation as a 
possible consequence o f chronic stress or allostatic load in Menière’s disease could 
not be confirmed by this study. Another consequence o f hippocampal atrophy, 
memory impairment was not studied in this setting. Earlier, we did find elevated 
cortisol levels and a higher frequency o f  not disease-related daily stressors in 
Menière patients compared to healthy people (135; 143). This could be associated to 
the more short-term stress-related consequences o f Menière’s disease. The 
hippocampal atrophy found in patients with chronic depression and posttraumatic 
stress disorder probably leads to more frequently elevated glucocorticosteroid levels 






The best way to interpret the complex process o f  the disabling Menière’s disease 
seems to be a continuous interaction o f  psychological, somatic and environmental 
factors. It is opted, that the process is becoming a vicious cycle: symptoms o f the 
disease could worsen the emotional, physical and social state, which in turn could 
worsen the (perception of) symptoms. This cycle is presented in the multifactor 
model o f  Menière’s disease in chap ter 4, where all factors o f this process have been 
put forward (Figure 1). In this paragraph, all the separate elements o f the model, 
either published by others or shown in our studies, are presented and discussed.
The first element o f  the process is endolymphatic hydrops. That 
endolymphatic hydrops causes Menière’s disease, is taken as a fact in the model 
based upon other studies (7; 144). However, not every patiënt with endolymphatic 
hydrops experiences the clinical triad o f  M enière’s disease (10) and endolymphatic 
hydrops could be an epiphenomenon in Menière’s disease (8). Patients are 
considered having Menière’s disease when their audiovestibular complaints 
(vertigo, hearing loss and tinnitus) are conform the “Definition Menière Groningen 
2001” (14).
The trias o f Menière symptoms may be conceived as stressor next to other 
incoming stressors. Stressors are handled with certain coping strategies and 
personality features (appraisal) and may generate specifïc psychological, 
physiological and behavioural responses. Consequently, this results in a particular 
emotional and behavioural state. These last elements were evaluated in chap ter 6, 
where a psychological assessment o f  Menière patients took place. It was found that 
Menière patients experience more daily hassles (stressors), use coping strategies less 
frequently (appraisal) and have more psychopathology (emotional stress response) 
and a worse quality o f life compared to healthy people. The psychopathology 
consisted o f depression, anxiety, agoraphobia and sleeping problems. No abnormal 
personality features were found. In previous studies was also shown that Menière 
patients experience more anxiety, depression and phobia (50;51;57). In the field of 
personality characteristics earlier studies have described Menière patients as 
obsessive-compulsive persons, perfectionists and neurotics, who are supposed to be 
more vulnerable and have more stress exposure (39;41;52), while others classified 
the personality o f  Menière patients in the normal range (54). A time-series analysis 
o f  stress and vertigo expression did not support the role o f  stress as a precursor o f 
symptoms in Menière’s disease (55). On the contrary, Söderman et al. did find that 
emotional stress increased the risk o f getting a vertigo attack (117). Menière patients 
experience a bad quality o f life and vertigo seems to be the most influencing factor 
on the major implications o f this disease on their daily lives (58;59; 128). A strong 
sense o f  coherence (ability to cope with stressful situations) appears to be an 
important predictor o f Menière patients’ perception o f symptoms and quality o f life 
according to Söderman et al. (61).
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Figure I. Multifactor model in Menière’s disease.
HPA axis = Hypothalamus-Pituitary-Adrenal axis; ANS = Autonomie Nervous System
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The physiological stress response is activated through two ways, resulting in 
corticosteroid (cortisol and aldosterone) and catecholamine secretion (noradrenaline 
and adrenaline). Mateijsen et al. have already shown that the aldosterone levels were 
normal in patients with Menière’s disease (100). In chapter 5 was shown that serum 
and saliva cortisol levels were elevated in Menière patients compared to healthy 
Controls. The dexamethasone suppression test and catecholamine levels were 
normal. It is suggested that these higher cortisol levels are rather the result than the 
cause o f this chronic disease, because longer affected patients tended to have higher 
cortisol levels.
In chapter 7, the effect o f chronic stress or repetitive activation o f  the 
hypothalamus-pituitary-adrenal axis was assessed by measuring the hippocampal 
volume. In earlier studies was shown on MRI scans that in certain conditions with 
elevated cortisol levels (e.g. depression, Cushing’s disease and posttraumatic stress 
disorder) hippocampal atrophy was present (74;75;77-79). Some researchers did not 
find differences between hippocampal volumes o f depressed patients and control 
subjects (109; 137). It was shown in our study that the hippocampi o f Menière 
patients were normally sized (no atrophy). So, effects o f  chronic stress due to 
elevated cortisol levels (allostatic load) were not observed in patients with Menière’s 
disease and the negative feedback o f cortisol production was supposed to be normal.
It is suggested that, when all these separate factors are put together, they 
might create a vicious cycle depending on how intense the stress responses are. This 
is supposed to be different for every individual patiënt. Unfortunately, it is 
statistically not allowed to make this model causative due to limited numbers of 
included patients and too many parameters in the model. Therefore, we only use this 
model to illustrate our thoughts and present elements conceming the psychological 
side o f the disease. The results are presented as descriptive studies. We recommend 
studying larger amounts o f patients to evaluate the possible causal relations o f  the 
presented model.
Discussion
From these study results can be concluded that there are noteworthy psychological 
and physiological effects in Menière’s disease. The question is whether this is 
specifïc for Menière’s disease or common as in many other chronic diseases. From 
the psychological assessment it could be concluded that the quality o f life o f 
Menière patients, which is a summation o f the mental, physical and social state, is 
comparable to that for other chronic diseases as migraine and, to a lesser extent, 
rheumatoid arthritis. However, it remains remarkable that Menière patients 
experience more daily hassles and use coping strategies less frequently than healthy 
Controls. This could be an effect o f  a chronic disabling disease by getting a reduced 
mental state. But, it could also be present prior to disease and consequently create 
allostatic load. Whether this possible allostatic load initiates Menière symptoms or 
Menière’s symptoms are the last piece to initiate the vicious cycle, remains 
unanswered. On the other hand, effects o f  allostatic load could not be confirmed,
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because normal hippocampal volumes were measured in patients with Menière’s 
disease.
The presence o f  higher levels o f  cortisol in Menière patients could be more or 
less the result o f  having a stressful disease. Chronic effects o f  stress were absent, 
since the dexamethasone suppression test results and hippocampal volumes were 
normal. This means that the hypothalamus-pituitary-adrenal axis is not 
dysfimctional, but only producing more cortisol. New insights to the role o f  cortisol 
have suggested that the physiological function o f stress-induced increases o f cortisol 
levels is not to protect from the source o f stress itself, but from the normal defence 
reactions (103). Furthermore, it has been shown that cortisol impairs auditory acuity, 
whereas sensory processing and perceptual integration may be improved (93;94). 
Relating these facts to Menière’s disease, the higher cortisol levels could be a 
(semi-) late effect o f the stressful disease. It has been shown in animal models that 
certain stress hormones increase endolymph production (83). This is only suggested 
for the human situation and has never been proven. The question remains whether 
cortisol can produce endolymphatic hydrops and/ or Menière symptoms.
The ratio behind the formulation o f the questions dealt with in this thesis was 
based upon the perception from clinical practice that Menière patients have certain 
personality characteristics, namely that they are obsessive-compulsive, aim for 
perfection and present themselves with a long chronological list o f  symptoms. This 
generalisation seems to be a misinterpretation, as can be concluded from our study 
results. O f course, every individual responds differently to disease and there will 
certainly be Menière patients who get obsessed by the symptoms and the disease. 
But our study showed that on the whole the personality o f the studied Menière 
patients was in the normal range. So, the perception o f  the physician is probably 
based on those patients who have the most trouble in handling their disease and who 
want to control not only their disease but most o f  the things in daily life. More or 
less the same personality profile as in Menière patients has also been suggested in 
patients with migraine and asthma, but has never been proven in psychological 
studies (131; 133). Our department is slightly biased in investigating the personality 
profile o f Menière patients, since many Menière patients come to our clinic for 
second opinions. This means that the more severe and chronic cases o f  M enière’s 







Menière’s disease is a chronic inner ear disease with handicapping symptoms as 
spontaneous vertigo attacks, progressive hearing loss and tinnitus. Endolymphatic 
hydrops is the most commonly used pathophysiologic model, but the exact 
pathogenesis remains unclear. There is no curative treatment available for Menière’s 
disease, so any treatment remains symptomatic.
M enière’s disease is amongst the conditions in which psychological factors 
are often emphasised. Many researchers have reported emotional disturbances in 
patients with Menière disease. Others have suggested that Menière patients have 
specific personality traits. These observations seem to have led to the conclusion 
that psychological factors could play a role in the development and continuation of 
Menière’s disease. Therefore, Menière’s disease has received a lot o f attention from 
a psychological point o f  view. A review o f psychological oriented studies in patients 
with Menière’s disease is presented in chap ter 2.
General aspects o f stress and relations between stress (hormones) and 
bodily systems, especially inner ears and Menière patients, are exposed in chap ter
3. It includes old and new facts about stress and presents clear definitions o f most of 
the elements involved in the stress cascade.
In chap ter 4, the suggested vicious cycle of psychological aspects and 
Menière’s disease including other factors are shown. The presented multifactor 
model is used to explain certain aspects o f  M enière’s disease other than the usual 
symptoms. Furthermore, the aims o f this thesis are introduced.
In chap ter 5, cortisol and catecholamine levels o f  patients with Menière’s 
disease were evaluated in a controlled setting. The serum and saliva cortisol levels 
were higher in Menière patients compared to their control group, 440 ± 127 (n=28) 
versus 366 ± 90 nmol/1 (n=18) and 17.2 ± 6.1 (n=18) versus 11.6 ± 4.6 nmol/1 (n=9), 
respectively (p<0.05). There were no dissimilarities in urine cortisol and urine 
catecholamines for both groups. Menière patients (n=28) were divided into two 
subgroups, high (HC) and low cortisol group (LC) using a serum cortisol level 
cutoff point o f 465 nmol/1 (median). The total Menière disease time and the duration 
o f tinnitus tended to be longer in the HC group (p=0.07, two-tailed). The total 
Menière disease time was 13.5 ± 9.9 versus 7.1 ± 7.4 years in the HC versus LC 
group (both n=14). The subgroups were matched for age, gender and uni- or 
bilaterally affected ears. It was concluded that patients with Menière’s disease have 
higher serum cortisol levels. It was suggested that it was rather the result than the 
cause o f this chronic disease, because patients who were longer affected by the 
disease, seemed to have higher cortisol levels.
In ch ap te r 6, a psychological assessment o f  Menière patients took place. The 
objective o f  this study was to evaluate daily stressors, coping, personality, physical 
and mental health and quality o f  life in Menière patients. 110 consecutive patients 
with definite M enière’s disease were assessed using the Dutch Daily Hassles List, 
Coping Inventory for Stressful Situations (CISS), Symptoms Checklist 90 (SCL-90), 
NEO Five Factor Inventory (NEO-FFI), General Health Questionnaire (GHQ-12)
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and the Short Form Health Survey 36 (SF-36). Duration and subjective severity o f  
symptoms were scored using a self-report questionnaire. It was shown that Menière 
patients had more daily stressors, used coping strategies less frequently, and had 
more psychopathology (e.g. anxiety and depression) and a worse quality o f  life 
compared to the general population. No abnormalities in personality structure were 
found. Patients with more severe symptoms had more psychopathology and a worse 
quality o f  life than patients with mild symptoms. Patients with either mild or severe 
symptomatology did not differ in personality or coping strategies. The deviant 
psychological profile o f  Menière patients seems comparable to patients with other 
chronic diseases. It is advised that psychosocial support should be intensified in 
certain patients with this disabling disease.
In chap ter 7. the effect of chronic stress (allostatic load) was assessed by 
measuring hippocampal volume. Hippocampal atrophy is known to be caused by 
chronically or repetitive elevated levels o f  cortisol. The hippocampal volumes o f  10 
Menière patients and 10 matched healthy Controls were measured on MRI scans. No 
differences in hippocampal volumes (corrected for head size) were found between 
the two groups. It was concluded from this pilot study that no signs o f chronic stress 
(hippocampal atrophy) were present in Menière patients.
Conclusions
Menière patients have a deviant psychological profile compared to the general 
population, but more or less comparable to the profile o f  patients with other chronic 
diseases. The higher cortisol levels in Menière patients implied an overproducing 
HPA axis in some way. Nevertheless, effects o f chronically elevated cortisol levels 
could not be found by measuring normal hippocampal volumes in patients with 
M enière’s disease. What the exact impact o f  the deviant psychological profile and 
higher cortisol levels on Menière’s disease, the inner ear and endolymph 
homeostasis could be, is yet unknown.
It is thought that the presented factors, symptoms and stress responses, seem 
to interact in a vicious cycle. What can we do to interrupt this suggested vicious 
cycle o f  symptoms, their effect on the state o f  mind and vice versa? First we have to 
keep in mind that every Menière patients needs individual treatment depending on 
the severity o f symptoms and impact o f the disease. Reducing the severity o f 
symptoms can be achieved with hearing aids and medication. Furthermore, we need 
to intensify the psychosocial support. The coping strategies and psychopathology 
(e.g. anxiety and depression) should be approached by a psychologist or psychiatrist. 
The impact o f the disease on daily functioning (mental, physical and social) should 
also be a point o f  attention. When Menière patients are helped with these issues, 






De ziekte van Menière is een chronische, invaliderende ziekte, waarbij de oorzaak in 
het binnenoor (slakkenhuis en evenwichtsorgaan) ligt (Figuur 1). De ziekte wordt 
gekenmerkt door progressief gehoorverlies, oorsuizen en aanvallen van 
draaiduizeligheid, gepaard gaande met misselijkheid en braken. In Nederland lijden 








Figuur 1. Het oor.
Prosper Menière, een Franse arts, was de eerste die het ziektebeeld als 
zodanig beschreef in 1861 (Figuur 2). Een teveel aan binnenoorvloeistof 
(endolymfe), ook wel endolymfatische hydrops genaamd, lijkt de oorzaak. Het 
exacte mechanisme voor het ontstaan van de ziekte van Menière en endolymfatische 
hydrops is nog niet duidelijk. Tot op heden is er geen genezende behandeling voor 
de ziekte van Menière, waardoor de behandeling dan ook gericht is op vermindering 
van klachten.
Psychologische aandoeningen, zoals angst en depressie, worden vaak bij 
patiënten met de ziekte van Menière gezien. Sommigen veronderstellen dat Menière- 
patiënten een dwangmatige en introverte persoonlijkheidsstructuur hebben en dat 
stress een rol zou kunnen spelen in de ontwikkeling o f  instandhouding van de ziekte 
van Menière. In de klinische praktijk worden aanwijzingen voor deze theorie 
waargenomen. In hoofdstuk 2 staat een samenvatting van de meest recente 
literatuur over dit onderwerp. Vanuit eerdere studies en de klinische praktijk 
ontwikkelde zich de hypothese dat er een soort vicieuze cirkel zou kunnen ontstaan. 
Hierin hebben de ziektesymptomen een negatieve invloed op de sociale, 




Figuur 2. Prosper Menière 1799-1862.
Dit veronderstelde proces is afgebeeld in een model, waar vele factoren van 
belang zijn (Figuur 3). In hoofdstuk 3 bevindt zich een uiteenzetting van oude en 
recente aspecten van stress, definities en de invloed van stress op het binnenoor en 
de ziekte van Menière. In dit model wordt stress gedefinieerd als een situatie die 
door een individu als bedreigend wordt geïnterpreteerd (stressvolle gebeurtenis) en 
die een aantal lichamelijke, psychologische en gedragsmatige reacties 
(,stressreacties) teweegbrengt. Hierbij is de perceptie o f  evaluatie van de stressor 
van belang en afhankelijk van de persoonlijkheid o f persoonlijke strategie hoe om te 
gaan met stress (coping). Meerdere factoren van dit model zijn in een drietal studies 
onderzocht, waarvan een uiteenzetting in hoofdstuk 4 staat.
In dit model wordt er vanuit gegaan dat endolymfatische hydrops de eerste 
factor is. Dit gegeven wordt in dit proefschrift aangenomen en niet bestudeerd. 
Patiënten worden verondersteld de ziekte van Menière te hebben als ze voldoen aan 
de “Definitie Menière Groningen 2001”. Dat houdt in dat ze tenminste 2 
draaiduizeligheidsaanvallen van langer dan 20 minuten moeten hebben gehad, plus 
oorsuizen en een gehoorverlies van minimaal 60 decibel als som van de drie 
slechtste octaven.
De lichamelijke stressreactie wordt bestudeerd in hoofdstuk 5 door evaluatie 
van stresshormonen bij Menière-patiënten. Stress leidt tot een toename in 
stresshormoonproductie via twee wegen, namelijk via de bijnierschors (hypofyse) en 
het bijniermerg (autonome zenuwstelsel). Het eerstgenoemde systeem produceert 
aldosteron en cortisol en het tweede produceert adrenaline en noradrenaline. 
Adrenaline heeft onder andere invloed op de bloeddruk en hartfrequentie. Cortisol 
zorgt voor het vrijkomen van glucose uit de energievoorraad in het lichaam en 
onderdrukt ontsteking. We toonden in onze studie aan dat de bloed- en 
speekselspiegels van cortisol hoger waren bij Menière-patiënten dan bij gezonde 




Figuur 3. Multifactor model bij de ziekte van Menière.
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Er wordt gesuggereerd dat stress en vooral de lichamelijke stressreacties van 
invloed zijn op het binnenoor en tot ontwikkeling o f instandhouding van de 
Menière-symptomen kunnen leiden. In diermodellen is aangetoond dat 
stresshormonen een toename in endolymfeproductie kunnen veroorzaken. 
Mogelijkerwijs geldt dit ook in de humane situatie. In het menselijke binnenoor zijn 
receptoren voor bepaalde stress hormonen aangetoond. Echt sluitend bewijs voor 
deze relatie is er niet.
Ten tweede is een studie opgezet om de psychologische factoren rondom de 
ziekte van Menière te verhelderen (hoofdstuk 6). Hierbij werden de gedragsmatige 
en psychologische stressreacties onderzocht. In de gedragsmatige stressreactie 
leiden chronische stressoren bijvoorbeeld tot het stoppen met werken o f  opleiding, 
overmatig alcoholgebruik o f  zelfs zelfdoding. De psychologische stressreactie geeft 
angst en woede in de acute situatie en gespannenheid o f depressiviteit als de 
stressoren aanhouden. Met behulp van zelfbeoordelingvragenlijsten zijn dagelijkse 
problemen, persoonlijkheid, coping, psychopathologie en kwaliteit van leven 
onderzocht. Onder de kwaliteit van leven wordt verstaan de impact van de ziekte op 
het sociaal, fysiek en psychisch functioneren in het dagelijkse leven. Deze studie liet 
zien dat Menière-patiënten meer alledaagse problemen hadden, copingstrategieën 
minder vaak gebruikten, meer psychopathologie (o.a. angst en depressie) en een 
slechtere kwaliteit van leven hadden. Er werden geen afwijkende 
persoonlijkheidskenmerken geconstateerd. De kwaliteit van leven van Menière- 
patiënten is vergelijkbaar met die van patiënten met andere chronische ziekten, zoals 
migraine en reuma. De resultaten van de psychologische evaluatie kwamen overeen 
met andere psychologisch georiënteerde studies bij Menière-patiënten. Alleen 
werden in de andere studies een beperkt aantal factoren onderzocht en waren nog 
nooit eerder alle verschillende elementen in één studie geanalyseerd.
Uit de literatuur is bekend dat een langdurige blootstelling aan hoge 
cortisolspiegels een beschadiging van de hippocampus (hippocampusatrofie) kan 
geven. De hippocampus bevindt zich in de linker en rechter hersenhelft en is van 
belang is bij leren, geheugen en emotie. Ook heeft de hippocampus een remmende 
werking op de cortisolproductie. Bij hippocampusatrofie vindt er ten tijde van stress 
dus een beperkte remming op cortisolproductie plaats, waardoor hogere 
cortisolspiegels worden waargenomen. Hippocampusatrofie is aangetoond bij 
mensen met depressie en de ziekte van Cushing, en bij de oudere mens. Het gaat 
hierbij om situaties waarbij langdurige stress en verhoogde cortisolspiegels een rol 
spelen. Er werd verondersteld dat Menière patiënten een al langdurig bestaande 
verhoogde stressbelasting hebben, waarbij zij hippocampusatrofie zouden kunnen 
ontwikkelen. In hoofdstuk 7 werd de grootte van de hippocampus van Menière 
patiënten vergeleken met die van gezonde proefpersonen van gelijk geslacht en 
gelijke leeftijd. Met behulp van MRI-scans kon de hippocampus worden afgetekend 
en de grootte worden berekend als maat voor de beschadiging c.q. atrofie van de
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hippocampus. Het bleek dat de Menière-patiënten en gezonde proefpersonen een 
vergelijkbare grootte van de hippocampus hadden.
Concluderend kunnen we zeggen dat Menière-patiënten een afwijkend 
psychologisch profiel hebben ten opzichte van de algemene populatie, maar 
vergelijkbaar met het profiel van patiënten met andere chronische ziekten. De 
hogere cortisolspiegels bij Menière-patiënten impliceren een overstimulatie van het 
stresssysteem. Een effect van langdurige blootstelling aan hoge cortisolspiegels, te 
weten hippocampusatrofie, werd niet aangetoond. Hoe het afwijkende 
psychologische profiel en de hoge cortisolspiegels met de ziekte van Menière, het 
binnenoor en de binnenoorvloeistofhuishouding in relatie zouden kunnen staan, is 
nog onbekend.
Waar kan worden ingegrepen in de gesuggereerde vicieuze cirkel van 
klachten, hun effect op de mentale, lichamelijke en sociale toestand en vice versa? 
Allereerst, elke Menière-patiënt heeft individuele hulp nodig, afhankelijk van de 
ernst van de symptomen en de impact op het dagelijkse leven. Hoortoestellen en 
medicijnen kunnen hierbij de symptomen verlichten. Verder zou bij een groep 
patiënten psychosociale hulp van belang kunnen zijn. De copingstrategieën en 
psychopathologie (angst en depressie) kunnen door een psycholoog o f psychiater 
worden behandeld. Uiteraard dient de impact van de ziekte op het dagelijkse leven 
(mentaal, lichamelijk en sociaal) te worden besproken en indien nodig behandeld. 
Menière-patiënten functioneren en voelen zich beter als ze met deze zaken worden 
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